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Lipids serve important functions as 
membrane constituents and also as 
energy storing molecules. Besides that, 
lipids and lipid structures participate 
directly as messengers or regulators 
of signal transduction. Despite the 
growing interest in the biology of 
lipids, the exact mechanisms how lipid 
homeostasis ties in with other systems 
in the cell to regulate cell physiology 
at large has still remained largely 
unstudied. The tiny nematode C. 
elegans has proven to be an efficacious 
model for studying various biological 
processes, in this thesis it was used 
to elucidate the importance of dietary 
fats, PUFAs and their derivatives in 
essential functions like development, 
breeding and feeding. 
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ABSTRACT  
 
Use of the nematode Caenorhabditis elegans in laboratory experiments has, since its 
implementation as a model organism over more than half a century ago, proven to be an 
efficacious alternative to other, often cost- and time-consuming experimental animals. 
Despite an apparently simple body plan of nematodes, C. elegans possesses sufficient 
cellular complexity and a number of evolutionally conserved disease pathways shared 
with higher organisms. It can therefore be a valuable disease model if the disease can be 
defined on a molecular basis. Although C. elegans lipid metabolism has some traits not 
present in mammals and vice versa, the basic processes of lipid synthesis and degradation, 
as well as pathways involved in regulation of lipid homeostasis are readily comparable. 
In the first section of this dissertation, the advantages of the worm model were exerted to 
study the mechanisms of action of elaidic acid, a fatty acid trans-isomer present in western 
diet disreputable for its detrimental effects on human health. In contrast to the 
undetectable response to trans-fat diet of wildtype worms, elaidic acid significantly 
reduced the viability and fertility of poly-unsaturated fatty acid (PUFA) deficient mutants. 
Subsequent microarray analysis revealed over-representation of development-related 
genes in response to trans-fat treatment. 
The second section of the dissertation considers the nematode as a model for studying 
endocannabinoid system (ECS). Due to lack of functional homologues of mammalian 
cannabinoid receptors ECS was previously presumed to be absent in this phylum of 
animals. The detection of endocannabinoids (EC), endogenous cannabimimetic signaling 
lipids, in nematodes, gives a hint of a functional endocannabinoid system. Transgenic 
worms expressing human cannabinoid receptors in nervous system showed attenuation of 
starvation-induced decrease of EC levels, suggesting the existence of a receptor mediated 
response.  
In conclusion, the dissertation describes the suitability of the nematode model for various 
lipid studies, implementing both phenotypic assays on individual worms as well as high-
throughput transcriptomics and lipidomics. 
 
National Library of Medical Classification: 
Medical Subject Headings (MeSH): Free Fatty Acids, Model Organism, Diet, Transcriptomics, Microarray, 
LC/MS,  Endocannabinoids, Anandamide, 2-Arachidonoyl glycerol, Transgenic C. elegans
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VII 
Reisner, Kaja 
Rasvahappojen ja endokannabinoidien fysiologinen rooli Caenorhabditis elegans- sukkulamadossa. 
Itä-Suomen yliopiston julkaisuja. Terveystieteiden tiedekunnan väitöskirjat  100. 2012. 80 p. 
 
ISBN (print): 978-952-61-0703-5 
ISBN (pdf): 1798-5706 
ISSN (print): 1798-5706 
ISSN (pdf): 978-952-61-0704-2 
ISSN-L: 1798-5714 
 
 
TIIVISTELMÄ 
 
Caenorhabditis elegans -sukkulamadon käyttö laboratoriokokeissa malliorganismina jo yli 
50 vuoden ajan on osoittautunut tehokkaaksi vaihtoehdoksi muille, usein kalliille ja aikaa 
vieville koe-eläimille. Huolimatta ilmeisen yksinkertaisesta rakenteestaan C. elegans -
sukkulamadolla on riittävän monimuotoisia soluja sekä lukuisia evoluutiossa säilyneitä 
korkeampien eliöiden kanssa yhteisiä sairausprosesseja. Siten C. elegans voi toimia 
arvokkaana tautimallina, mikäli sairaus voidaan määrittää molekylaarisella tasolla. Vaikka 
C. elegans- sukkulamadon rasva-aineenvaihdunnan joitain piirteitä ei olekaan nisäkkäillä 
ja päinvastoin, rasvahappojen synteesin ja hajotuksen perusprosessit samoin kuin rasva-
aineenvaihdunnan tasapainotilan säätelyyn osallistuvat reaktiotiet ovat vertailukelpoisia.  
Väitöskirjan ensimmäisessä osassa sukkulamatomallia hyödynnettiin elaidiinihapon 
toimintamekanismien tutkinnassa. Elaidiinihappo on länsimaisessa ruokavaliossa 
esiintyvä rasvahapon huonomaineinen trans-isomeeri, jota pidetään vahingollisena 
terveydelle. Elaidiinihappoa sisältävä ruokavalio ei aiheuttanut havaittavaa reaktiota 
villityypin madoissa, mutta mutanttimadoissa, joilta puuttuivat monityydyttymättömät 
rasvahapot (PUFA), siitä seurasi alentunut elinkelpoisuus ja hedelmällisyys. 
Mikrosirututkimus osoitti transrasvaruokavalion johtaneen näillä madoilla kehitykseen 
osallistuvien geenien ilmentymisen yliedustukseen. 
Väitöskirjan toisessa osassa tarkastellaan sukkulamatoa endokannabinoidijärjestelmän 
(ECS) tutkimuksen mallina. Koska sukkulamadoista ei ole löytynyt toiminnallisia 
homologeja nisäkkäitten kannabinoidireseptoreille, endokannabinoidijärjestelmän on 
oletettu puuttuvan tästä eliöitten pääluokasta. Endokannabinoidien, endogeenisten 
kannabinoideja jäljittelevien viestilipidien, löytyminen sukkulamadosta tässä 
tutkimuksessa viittaa kuitenkin toiminnalliseen endokannabinoidijärjestelmään.  Ihmisen 
kannabinoidireseptoreita hermostossaan ilmentäneissä siirtogeenisissä sukkulamadoissa 
nälkiintymisen aiheuttama endokannabinoiditasojen lasku vaimentui, mikä vihjaa 
reseptorivälitteisen vasteen olemassaoloon. 
Yhteenvetona voidaan todeta tämän väitöskirjatyön havainnollistavan sukkulamatomallin 
soveltuvuutta moniin rasva-aineenvaihdunnan tutkimuksiin, yksittäisten matojen 
ilmiasun selvittämisestä aina laajasti seulovaan transkriptomiikkaan ja lipidomiikkaan. 
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1 Introduction  
 
 
The physical properties of membrane lipids, like the degree of unsaturation as well as the 
positional and conformational isomerism of fatty acyl chains, determine the cell 
membrane organization and functioning. The lipids of biological membranes can exist in 
multiple possible phase states with specific properties. These phase states determine the 
orientation and mobility of membrane lipids and proteins, and will therefore affect 
membrane functionality. Lipid mixtures rich in sphingomyelin with saturated 
hydrocarbon chains tend to adopt solid-like phases; unsaturated hydrocarbon chains tend 
to be enriched in a liquid-disordered phase. 
Membrane proteins, including key signal transduction proteins, are often localized in 
liquid ordered domains surrounded by highly disordered phospholipid bilayer (Brown 
and London, 1998, Vereb et al., 2003). These liquid-ordered domains, also known as 
“membrane rafts”, form as a mixture of bilayer-forming lipids and sterols and have the 
high order of a solid but the high translational mobility of a liquid.  
Unsaturation of a carbon-carbon double bond leads to shape change in hydrocarbon chain 
- the cis configuration with hydrogen atoms on the same side induces a “kink” in the acyl 
chain. Thus, the phospholipids containing unsaturated acyl chains cannot pack as tightly 
as those with saturated acyl chains, and the fluidity of the lipid bilayer is proportional 
with the degree of unsaturation of its fatty acid components.  
Linoleic and α-linoleinic acid, the respective precursors of long- chain ω-6 and ω-3 
polyunsaturated fatty acids (PUFAs), are considered essential to the mammalian diet as 
vertebrates lack the enzymes required for their de novo synthesis (Δ-12 and ω-3 desaturase, 
respectively). The highly unsaturated arachidonic (AA; 20:4n6) and docosahexaenoic 
(DHA; 22:6n3) acid are major building blocks of cellular membranes (Svennerholm, 1968). 
When released through phospholipase action, HUFAs (highly unsaturated fatty acids with 
four or more double bonds) can take part in regulation of many cellular processes either 
directly or by being converted into different lipid mediators. For example, twenty-carbon 
PUFAs are the progenitors of eicosanoids (including prostaglandins) - molecules involved 
in inflammation and immunity as well as signalling in CNS. Whereas the ω-6 eicosanoids 
are considered generally proinflammatory, the ω-3 eicosanoids tend to soften the 
inflammatory effects of ω-6 (reviewed in Funk, 2001; Simopoulos, 2002a). In light of this, 
the right ω-6 and ω-3 dietary ratio is vital for human health (Simopoulos, 2009).  
Furthermore, under certain circumstances, an unsaturated double bond can acquire a trans 
conformation where the hydrogen atoms reside on opposite sides of the hydrocarbon 
chain. These trans fatty acid (TFA) molecules have a linear shape resembling saturated 
chains, but possess an intrinsic disorder approaching that of a cis unsaturated chain. 
Dietary trans fats, mostly found in partly dehydrogenated plant of fish oils, are shown to 
be readily incorporated into cell membranes  and are associated with several disease states 
(reviewed in Gebauer et al., 2007; Mozaffarian et al., 2009). Still, the molecular mechanism 
of detrimental effects on health remains to be determined. One would hypothesize, that 
the TFAs would substitute into membrane lipids and, looking like saturated yet acting like 
  
2
unsaturated fatty acids, disrupt the normal molecular organization of the cell membrane, 
hence leading to malfunctioning of cellular processes and signaling pathways. 
We used the model organsim Caenorhabditis elegans to investigate the effect of dietary TFA 
on cellular processes. C. elegans is a ~1mm in length nematode that can be easily cultivated 
on Petri dishes with agar medium seeded with Esherichia coli. Despite its small and simple 
body anatomy, about 35% of C. elegans genes have human homologs, hence these 
roundworms can provide a convenient way for researchers to test hypotheses about the 
main conserved biochemical pathways.  
The C. elegans lipid metabolism pathways largely resemble mammalian pathways, with 
only a few exceptions. Unlike mammals, nematodes have no dietary requirements for 
essential fatty acids, as they possess all the required fatty acid biosynthetic enzymes, 
however they are unable to produce longer than C20 PUFAs, so the ω6 and ω3 PUFA 
biosynthesis pathways end with arachidonic acid (20:4n6) and eicosapentaenoic acid 
(20:5n3), respectively (Watts and Browse, 2002).  
Feeding elaidic acid (trans isoform of oleic acid, 18:1n9) triglycerides to wild type C. elegans 
during three generations did not result in any significant changes in viability or fertility of 
the worms. However, the Δ6-desaturase mutant fat-3 worms became evidently sick living 
on a trans fat diet, showing reduction in both life span and brood size. The toxic effect of 
dietary trans fat was particularly robust in the third generation of mutant worms grown 
on agar plates enriched with elaidic acid. We also preformed a microarray gene expression 
and subsequent Gene Ontology analysis on fat-3 mutant worms, to reveal the effect of 
trans fat diet on the cellular level.  
Besides eicosanoids involved in inflammatory response, arachidonic acid (AA) can also be 
converted into endocannabinoids like anandamide (AEA) and 2-AG. The 
endocannabinoid system (ECS) was discovered in early 1990s and has since then been 
intensively studied. The list of pleiotropic biological effects ascribed to this network 
indicates the complexity of ECS: in addition to its roles in peripheral modulation of the 
immune system, vascular beds, neuroprotection, reproductive organs, gastrointestinal 
motility and metabolism, it also regulates various aspects of cognitive functions including 
learning and memory, anxiety, depression, pain, addiction, appetite and feeding behavior 
(for review see Kano et al., 2009), thus affecting both physiological and mental processes. 
It is not known whether C. elegans produces eicosanoid effectors from C20 PUFAs. 
However, the worm contains 80 cytochrome P450 genes, some of which may be capable of 
forming epoxy (EET), hydroxy (HETE), and lipoxin products from PUFAs (Menzel et al. 
2001). We have identified two AA derived endocannabinoid molecules AEA and 2-AG, as 
well as several cannabinoid receptor inactive cannabimimetic N-acylethanolamides in 
nematodes C. elegans, C. briggsae, and Pelodera strongyloides. Although C. elegans seems to 
lack enzymes for 2-AG biosynthesis and degradation as well as functional cannabinoid 
receptor homologs (McPartland et al., 2006), presence of the major endocannabinoids and 
at least some of the genes encoding (putative) homologs of N-acyl-ethanolamide 
metabolism enzymes (McPartland et al., 2006) suggests the presence of a functional ECS in 
nematodes. Data from our experiments with transgenic worms ectopically expressing 
human cannabinoid receptors in the nervous system seem to support this assumption.  
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2 Review of the Literature 
 
 
2.1. Lipid molecules in cell membranes  
 
Lipids fulfill three general functions: 1) as energy storage, principally as triacylglycerol 
and steryl esters, in lipid droplets; 2) as first and second messengers in signal transduction 
and molecular recognition processes; 3) as the matrix of cellular membranes.  
The additional roles of lipids besides maintaining the cell structure and providing a 
bidimensional support for membrane proteins have for decades been underestimated. 
Only recently more attention has been paid to involvement of lipids in essential cellular 
processes e.g., cellular adhesion (Moya et al., 1979), toxin and pathogen attachment (Taïeb 
et al., 2004), signal transduction (Berridge, 1984; Vögler et al., 2004), and protein trafficking 
(Anderson and Jacobson, 2002).  
In eukaryotic cells, phospholipids are the predominant membrane lipids, consisting of a 
hydrophilic head group to which are attached hydrophobic acyl chains. These fatty acyl 
chains, or fatty acids, can be categorized as either saturates (SFAs), monounsaturates 
(MUFAs), or polyunsaturates (PUFAs), with the PUFAs being further divided into ω-3 (n-
3), ω-6 (n-6) and some ω-9 (n-9). The sn-2 position (sn refers to stereospecific numbering of 
carbons with the polar head group being attached to carbon number 3) of a membrane 
lipid is always an unsaturated acyl chain, the sn-1 position can be either a saturated or an 
unsaturated acyl chain. Both the chain length and the number of double bonds influence 
the physical properties of the lipids that contain them, thus also plasma membrane 
function (for review see Cribier et al., 1993). In mammalian tissue, the number of different 
fatty acids is about 30-60. The enormous structural diversity found in lipids (estimated 
1000 to 2000 different molecular species, not accounting glucolipids and lipoproteins) 
arises from various combinations of fatty acids and different head groups, typically linked 
to a backbone such as glycerol. 
For normal function, membrane bilayers must be ‘fluid’, allowing lateral movement of 
membrane components. To achieve this ‘fluidity’, it is essential for cell membranes to 
contain unsaturated acyl chains to a certain extent. While animals can synthesize both 
saturated (SFA) and monounsaturated (MUFA) acyl chains from acetyl co-enzyme A 
(acetyl CoA) and the proportion of these fatty acids in membranes remains relatively 
constant over a wide range of dietary variation, membrane composition seems to be much 
more responsive to dietary ω6 and ω3 PUFA levels, probably due to the inability of higher 
animals to de novo synthesize those fatty acids (Escudero et al., 1998).  
 
2.1.1. Membrane microdomains 
 
The membrane compartmentalization model (Anderson and Jacobson, 2002) has replaced 
the fluid mosaic model (Singer and Nicolson, 1972), cell plasma membranes are no longer 
considered as a two-dimensional liquid where all lipid and protein molecules diffuse 
randomly and more or less easily. Instead, it has been shown that plasma membranes are 
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non-uniform, and a substantial fraction of membrane lipids and/or proteins appear 
confined to submicroscopic membrane domains. Membrane proteins including key signal 
transduction proteins are often localized in such heterogenous self-organizing intrinsically 
unstable liquid ordered domains that act as large reaction platforms - up to a micron in 
scale, harboring enzymes, substrates and adaptor/scaffold proteins (Dietrich et al., 2001; 
Bhattacharyya et al., 2006). Although these microdomains are often referred to in literature 
as “lipid rafts”, the term “membrane raft” would be preferred, as proteins and lipids both 
contribute to the formation of these microdomains. Membrane rafts are small (10–200 nm), 
heterogeneous, highly dynamic, sterol- and sphingolipid-enriched domains that 
compartmentalize cellular processes. Small rafts can sometimes be stabilized to form 
larger platforms through protein-protein and protein-lipid interactions (Pike, 2006). 
Complexes smaller that 10 nm would be referred to as “lipid shells” (Anderson and 
Jacobson, 2002).  
The rafts are based on lipid–protein and protein-protein interactions in an environment 
where tight lipid interactions of cholesterol and/or sphingolipids create a lipid-ordered 
phase (Simons and Ikonen, 1997; reviewed in Zheng and Foster, 2009). In such 
microdomains in some cases, very large protein complexes can be formed (van Meer and 
Lisman, 2002). A complement of signaling proteins including certain G-protein-coupled 
receptors (GPCR), receptor tyrosine kinases (RTK), and post-receptor signaling 
components show localization in those microdomains, suggesting the role of membrane 
rafts in signal transduction (Foster et al., 2003; Patel et al., 2008; reviewed in Patel and 
Insel, 2009). In addition to cholesterol and sphingolipids, rafts are shown to contain 
biologically active lipids and precursors such as arachidonic acid (Pike et al., 2002). 
Membrane rafts are also considered the possible entry site of pathogenic bacteria into host 
cells (reviewed in Hartlova et al., 2010; Vieira et al., 2010). 
Subpopulations of rafts have been proposed, in part based on their size, constituents, and 
functional properties (Mishra and Joshi, 2007). While planar membrane rafts cannot be 
easily identified separately from other portions of the plasma membrane, caveolae are raft-
related domains of about 50–00 nm in size that become invaginated due to the presence of 
the structural protein, caveolin and are therefore identifiable by microscopy. Akin planar 
membrane rafts caveolae are rich in cholesterol and glycosphingolipids (Anderson, 1998) 
and contain a similar complement of signaling proteins (Sargiacomo et al., 1993; Schnitzer 
et al., 1995; Song et al., 1996). Caveolae have been suggested to function in signaling events 
through the compartmentalization of signaling molecules interacting with caveolin 
proteins, in clathrin-independent endocytosis, transcytosis, and potocytosis (Sargiacomo 
et al., 1993; Lisanti et al., 1994; Parton and Richards, 2003), and may be involved in the 
pathogenesis of various diseases (for review see Schwencke et al., 2006; Layne et al., 2011). 
They are also considered a compartmentalization site for endocannabinoid signalling 
including the endocannabinoid N-arachidonoyl ethanolamine (AEA) and its target, the 
cannabinoid receptor type 1 (CB1R) (Fielding and Fielding, 1997; Czarny et al., 1999; Keren 
and Sarne, 2003; McFarland et al., 2004). 
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2.1.2. Cholesterol 
 
The bilayer of phospholipids in cell membrane is interwoven with cholesterol and 
proteins. Cholesterol is an amphipathic molecule with a hydroxyl group aligning with the 
phosphate heads of the phospholipids, part of the steroid ring closely attracted to part of 
the fatty acid chain on the nearest phospholipid and the short branched hydrocarbon tail 
in the hydrophobic layer of the membrane. This helps slightly immobilize the outer 
surface of the membrane and reduces the permeability of the plasma membrane to 
hydrogen. While maintaining the membrane integrity and firmness, however, cholesterol 
also maintains the fluidity of the membrane by preventing crystallization of hydrocarbons 
and phase shifts in the membrane.  
Besides regulating the consistency of the cell membrane, cholesterol has an important role 
in cell signaling. Topological dissymmetry (planar smooth alpha face and rough beta face) 
allows one molecule of cholesterol to interact with two distinct membrane molecules, e.g., 
a sphingolipid through the alpha face (Garmy et al., 2005) and a transmembrane protein 
through the beta face (Epand et al., 2006). 
Membrane cholesterol is a major regulator of ion channel function (reviewed by Martens 
et al., 2004; Maguy et al., 2006; Levitan et al., 2010) and also required for the function of 
several G protein-coupled receptors (reviewed in Burger et al., 2000; Fantini and Barrantes, 
2009). The effect of cholesterol on membrane proteins can be attributed to modulation of 
the properties of the membrane bilayer, resulting in a decrease in the free volume 
available for molecular motion in the hydrophobic core of the bilayer (Mitchell et al., 
1990). In the “lipid belt” or “lipid shell” model (Fantini and Barrantes, 2009; Barrantes, 
2004; Marsh and Barrantes, 1978) a cholesterol molecule is proposed to be part of the lipid 
belt surrounding the channel affecting the hydrophobic interactions between the channels 
and the lipids.  The impact of cholesterol on different types of ion channels is highly 
heterogeneous. The most common effect is cholesterol-induced decrease in channel 
activity, however, there are also several types of ion channels that are inhibited by the 
removal of membrane cholesterol and in some cases changes in membrane cholesterol 
affect the voltage dependence of channel activation or inactivation (reviewed in Levitan et 
al., 2010). Finally, cholesterol may also affect the channels indirectly through interactions 
with different signaling cascades. 
 
2.1.3. Polyunsaturated fatty acids (PUFAs) 
 
Polyunsaturated fatty acids (PUFAs) affect many cellular and physiological processes in 
both plants and animals, including cold adaptation and survival (reviewed in Cossins et 
al., 2002; Hayward et al., 2007), modulation of ion channels (Meves, 2008 Xiao et al., 2001), 
endocytosis/exocytosis (Schmidt et al., 1999), pollen formation, pathogen defense, 
chloroplast development in plants (Wallis and Browse, 2002), alteration of membrane 
phospholipid composition and functionality of self-organizing lipid domains (reviewed in 
Ma et al., 2004; Zheng and Foster, 2009). Several studies indicate that increasing the level 
of PUFA in the diet elevates metabolic rate (Shimomura et al., 1990; Pan and Storlien, 1993; 
Takeuchi et al., 1995; Newman et al., 2002) and species with high metabolic rates have 
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highly polyunsaturated membranes while species with low metabolic rates have cellular 
membranes that are more monounsaturated (Hulbert and Else, 2000). 
 
2.1.3.1. PUFA biosynthesis 
The enzymes responsible for the regulation of membrane PUFA composition include 
elongases, desaturases, phospholipases and lysophospholipid acyl-transferases. Saturated 
fatty acids can be converted into monounsaturated oleic acid and further to long-chain 
(C20 and C22) and very long-chain (C28–C34) poly-unsaturated fatty acids (PUFAs) in a 
sequence of desaturation and chain elongation reactions. The desaturase enzymes are 
capable of introducing extra double bonds into acyl chains and elongases add extra 
carbons to the acyl chain (Sprecher et al, 1995). Elongation and unsaturation of fatty acids 
occurs in both the mitochondria and endoplasmic reticulum (microsomal membranes). 
Elongation is a four-step process that involves condensation of malonate and a fatty acid, 
mediated by a 3-ketoacyl synthase (elongase). Unlike fatty acid synthesis reaction where 
both substrates are acyl carrier protein thioesthers, elongation reaction substrates are CoA 
thioesthers. The condensation step product is two carbons longer and undergoes 
reduction mediated by 3-ketoacyl reductase, dehydration by 3-hydroxyacyl dehydratase 
and final reduction by enoyl reductase. The reduction reactions of elongation require 
NADPH as co-factor just as for the similar reactions catalyzed by FAS. The product of one 
elongation cycle regenerates a fatty acid that has been extended by two carbon atoms. 
The majority of desaturases in eucaryotic organsims are endoplasmatic reticulum (ER) 
membrane bound diiron-oxo proteins with three conserved histidine residues for 
coordinating two iron atoms at the active site of the cytosolic face of the ER and two long 
stretches of hydrophobic membrane spanning loops for anchoring the protein to lipid 
bilayer (reviewed in Shanklin et al., 2009). Besides desaturase enzyme, the reaction 
requires an electron transport system involving cytochrome b5 and NADPH-cytochrome 
b5 reductase. This complex system avoids generating H2O2 in the vicinity of the sensitive 
double bonds. Depending of the double bond position in the carbon chain, PUFAs can be 
divided to n-3 (also known as ω-3) and n-6 (also known as ω-6) PUFAs (double bond at 
third and sixth carbon–carbon bond, respectively counting from the terminal methyl 
carbon toward the carbonyl carbon).  
 
2.1.3.2. Essential fatty acids (EFAs) 
Whilst some invertebrate groups (e.g. nematodes) possess the desaturases required for de 
novo production of ω6 and ω3 polyunsaturates, these enzymes are absent in vertebrates 
and many other invertebrates. Therefore, it is essential for such species to obtain ω6 and 
ω3 PUFA progenitors, linoleate and α-linolenate, respectively, from diet. Deficiency of 
these ‘essential fatty’ acids (EFAs) impairs lipid and energy metabolism, polyunsaturated 
fatty acid (PUFA) synthesis, cell membrane structures and lipid signaling pathways and is 
incompatible with life (for review, see Cunnane, 2003). 
In case of EFA deficiency, oleic acid (18:1n-9) can also be converted to polyunsaturated 
mead acid (20:3n-9), but as desaturase and elongase enzymes have a substrate preference 
for 18 carbon PUFA, mead acid is normally not produced in any quantity. Also, the 
essentiality of linoelate and alpha-linolenate has been questioned by some authors 
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(Cunnane, 2003), since it has been shown that PUFA deficient rats can synthesize those 
fatty acids by elongation from their sixteen carbon (16:2ω6 and 16:3ω3) and even fourteen 
carbon (14:2ω6 and 14:3ω3) homologues (Sprecher, 1968). However, these molecules are 
not endogenously synthesized and usually not available in diet, at least not sufficiently to 
meet ω6 and ω3 PUFA requirements (Cunnane et al., 1995; Cunnane, 2003). 
 
2.1.3.3. Omega-6 to Omega-3 ratio 
Another important issue in LC-PUFA metabolism is the correct ω6 to ω3 ratio, which 
would be about 1 for humans, according to anthropological and epidemiological studies 
and studies at the molecular level (reviewed in Simopoulos, 2002b; Simopoulos, 2006). 
There is a competition between the two for desaturation enzymes, whereas both Δ4- and 
Δ6-desaturases prefer ω3 to ω6 (de Gŏmez Dumm et al., 1975; Hagve and Christophersen, 
1984). To meet ω6 PUFA requirements in healthy adults, 0.5 to about 1.5 % of energy 
intake as linoleate would be sufficient. Excessive amounts of ω6 PUFAs and a very high 
ratio, as is found in today’s Western diets 15–20/1, is believed to promote the pathogenesis 
of many diseases, including cardiovascular disease, cancer, and inflammatory and 
autoimmune diseases (reviewed in Simopoulos, 2006).  
 
2.1.4. Fatty acid trans isomers 
 
2.1.4.1. Sources of trans fatty acids 
TFAs are found in meat and dairy products to some extent (about 2- 9 % of bovine fats) 
since they are intermediates in fatty acid β-oxidation, and also formed in the rumen by 
bacterial hydrogenation (i.e. from bacterial biohydrogenation in the forestomach of 
ruminants) (Wilde and Dawson, 1966). Vaccenic acid (18:1n7t), a precursor for conjugated 
linoleic acid (CLA), is the major TFA isomer in ruminant fat (Weggemans et al., 2004). 
However, minor amounts of 18:1n9t, 18:1n10t and 18:1n12t are also produced (Sadler, 
2005). CLAs are a group of positional and geometric conjugated isomers of linoleic acid. 
The two predominant isomers, with known bioactive properties, are 18:2 (cis-9 trans-11), 
and 18:2 (trans-10, cis-12) (Rainer and Heiss, 2004). Some beneficial effects on health 
outcomes observed in animal studies have been ascribed to CLA, however, more research 
is needed in humans (reviewed in Bhattacharya et al., 2006; Salas-Salvado et al., 2006).  
However, most of the TFAs in human diet have industrial origin. Hydrogenation is a 
method to increase the thermal stability of liquid oils (mainly of vegetable origin, but also 
of fish oils) concomitantly altering their physical properties, producing solid fats and 
partially hydrogenated oils. In this process, cis unsaturated fatty acids are converted to 
either saturated fats or a mixture of trans and cis isomers. The C18:1t isomers comprise 
approximately 80–90% of total TFA in foods, with elaidic acid (EA, 18:1n9t) being the 
prevailing isomer present in partially hydrogenated fats. EA is also the TFA that has been 
most widely used in trans-fat related studies. 
A recent study by Balazy and Chemtob demonstrates that endogenous TFAs can originate 
not only from dietary sources but also from the pathobiochemistry of a disease process - 
concomitantly with production of nitroeicosanoids by the reaction of arachidonic acid 
(AA, 20:4n6) with the nitrogen dioxide radical (NO2) or its precursors, abundant formation 
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of four trans isomers of arachidonic acid (TAA) takes place via reversible addition of the 
NO2 radical to the arachidonic acid cis double bonds (Balazy and Chemtob, 2008). There is 
a significant increase of endogenous trans arachidonic acid (TAA) formation under 
immunostimulatory conditions and nitro-oxidative stress (Balazy, 2000), exposure to 
cigarette smoke (Zghibeh et al., 2004) and ischemic neuropathies (retinopathies and 
encephalopathies)(Kermorvant-Duchemin et al., 2005; Balazy and Chemtob, 2008). Still, in 
addition to the NO2-mediated isomerization, some of the TAA isomers could originate 
from dietary trans linoleic acid (trans-LA) precursors (Balazy and Chemtob, 2008).  
 
2.1.4.2. Effect of TFA on membrane structure and cell signaling 
The cis configuration, with hydrogen atoms on the same side of the double bond, induces 
a prominent kink in oleic acid (OA, 18:1n9c) compared to its analogs, trans-unsaturated 
elaidic acid (EA, 18:1n9t) and saturated stearic acid (SA, 18:0) that both have a linear 
molecular shape. The trans bond is more thermodynamically stable than the cis bond and 
is therefore less chemically reactive (Sadler, 2005). Due to their linear shape and stronger 
intermolecular chain–chain interaction, trans isomers can pack together more closely than 
their cis counterparts and have higher melting points. The torsional states preferred by the 
single bonds next to a trans or cis double bond differ markedly, the energy-minimized 
structure for EA is more similar to the linear configuration adopted by SA (Rey et al., 
1992). 
However, despite a conformation that somewhat resembles a saturated chain, TFA possess 
an intrinsic disorder approaching that of a cis unsaturated chain. Unlike a cis double bond, 
rotation about trans double bond is prohibited while the energy barrier to rotation about 
the immediately adjacent single bonds is reduced relative to that of a saturated chain 
(Emken, 1991). In addition to theoretical and computer simulation investigations, 
molecular organization of trans and cis isomers within a model membrane comprised of 
phosphatidylcholine (PC) molecules (Roach et al., 2004; Soni et al., 2009) has been studied. 
Comparison of cis and trans fatty acid containing 1-stearoyl-2-oleoyl-sn-glycero-3-
phosphocholine (18:0-18:1∆9c PC) and 1-stearoyl-2-elaidoyl-sn-glycero-3- phosphocholine 
(18:0-18:1∆9t PC), showed lower fluidity and a smaller area per molecule in the trans-
unsaturated system (Roach et al., 2004), qualitatively agreeing with a recent study by Soni 
and colleagues showing higher order for t18:1-18:0PC relative to c18:1-18:0PC (Soni et al., 
2009). However, contrary to the earlier study, Soni and colleagues found that although EA 
packs better than OA in gel phase, acyl chain order is only slightly greater in the EA-
containing membranes compared to OA, and much smaller than order for saturated 18:0-
18:0PC (Soni et al., 2009).  
As dietary TFA concentration is associated with the elevation of LDL cholesterol (Mensink 
and Katan, 1990; Nestel et al., 1992; Katan et al., 1995), Niu and colleagues studied the 
interaction of TFA with cholesterol and showed that phospholipid derived from TFA have 
40-80% higher membrane cholesterol affinity than their cis analogues (Niu et al., 2005). 
Also, sphingomyelin and phosphatidylcholine containing EA (N-E-SM and PEPC) are able 
to form ordered domains together with cholesterol and saturated phospho- and 
sphingolipids in model membranes (Björkbom et al., 2007). Taken into account that 
cholesterol and sphingolipids are the main constituents of lipid rafts (Simons and Ikonen, 
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1997), these results indicate that TFA might have an influence on raft formation in 
biological membranes, in turn modulating membrane structure and cell signaling. Oleic 
acid, either free or bound to other molecules, increases the tendency of the membrane to 
form hexagonal phase (Funari et al., 2003) and also regulates G protein activity in 
biological membranes, whereas its saturated and trans-counterparts do not possess these 
properties (Funari et al., 2003; Yang et al., 2005). In contrast to OA, β-oxidation of EA gives 
rise to a partially degraded substrate (14:1n5t) that tends to accumulate in the 
mitochondrial matrix (Yu et al., 2004). Despite similar molecular shape, vaccenic acid (VA, 
18:1n7t) and EA display dissimilar activity in β-oxidation and gene regulation (Du et al., 
2010), suggesting that positional isomerism leads to specific biochemical properties also in 
case of TFAs.  
Many authors (Gudheti et al., 2007; Björkbom et al., 2007; Soni et al., 2009) speculate that 
TFA could substitute into membrane lipids and locally affect molecular organization by 
being mistakenly identified as a saturated fatty acid (on the basis of its conformation) yet 
disrupting membrane order almost as much as its cis counterpart. This, in turn, can 
produce a change in protein activity adversely influencing biological function.  
 
2.1.4.3. Effects of dietary TFA on human health 
Dietary TFAs have been implicated for having potentially health hazardous effects 
(reviewed in Gebauer et al., 2007; Sadler, 2005; Mozaffarian et al., 2009), accused of 
increasing the risk of coronary heart disease (Ascerio et al., 2006; Mozaffarian et al., 2006), 
the development of diabetes (Hu et al., 2001; Salmeron et al., 2001; Odegaard and Pereira, 
2006), colorectal and other cancers (Vinikoor et al., 2008; Chajés et al., 2008; reviewed in 
Thompson et al., 2008) and infertility (Chavarro et al., 2007). Although epidemiological 
studies have shown serious health complications associated with the intake of trans-fatty 
acids their mechanism of action is yet poorly studied at the molecular level. 
 
 
2.2. FAT METABOLISM IN CAENORHABDITIS ELEGANS 
 
2.2.1. C. elegans fatty acid synthesis 
 
Worm lipids are derived from four sources: (1) direct absorption and incorporation of 
dietary fats, (2) absorption and modification of dietary fats by elongation and/or 
desaturation, (3) de novo synthesis, and (4) maternal inheritance. The standard strain of E. 
coli on which C. elegans are maintained in the laboratory contains palmitic (16:0), 
palmitoleic (16:1n7), vaccenic (18:1n7) and two cyclopropane fatty acids (C17D and C19D), 
but not stearic acid (18:0), oleic acid (18:1n9), monomethylbranched-chain nor 
polyunsaturated fatty acids (Tanaka et al., 1996; Watts and Browse, 2002; Kniazeva et al., 
2004; Perez and Van Gilst, 2008; ). 
Whereas the majority of fatty acids in worms grown on the standard E. coli strain OP50 
are directly obtained from ingested bacteria, worms can also be grown on axenic medium 
with no dietary fatty acids, indicating the presence of an enzyme system capable of de novo 
synthesis of all vitally important fatty acids (Houthoofd et al., 2002). However, wild-type 
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worms grow considerably slower under the axenic growth conditions, and the fatty acid 
profile is also dramatically different - worms accumulate higher levels of 16:0, 18:0, and 
18:1n9, while they produce lesser amounts of 20:5n3 (Brock et al., 2006). 
 
2.2.1.1. Saturated fatty acids 
Saturated fatty acids can be synthesized de novo from acetyl CoA by two enzymes: acetyl 
CoA carboxylase and fatty acid synthase. Acetyl-CoA is carboxylated by acetyl-CoA 
carboxylase (ACC) to form malonyl-CoA which is then elongated by fatty acid synthase 
(FAS) in a step-wise fashion to generate fatty acids of different lengths. FAS has been 
shown to have an important role in proliferation as a target of p53 family (D’Erchia et al., 
2006).  
When only 7% of the palmitic acid (16:0) is derived from de novo synthesis, C18 saturated, 
monounsaturated (MUFAs) and polyunsaturated (PUFAs) as well as monomethyl 
branched-chain fatty acids (mmBCFAs) rely more on de novo synthesis (up to 20 %) (Perez 
and van Gilst, 2008).  
 
2.2.1.2. Monomethyl branched-chain fatty acids  
C. elegans appears to use the same initial reactions to produce mmBCFAs as bacterial cells 
(Kniazeva et al., 2004). mmBCFA biosynthesis utilizes branched-chain α-keto-acids of 
leucine, isoleucine, and valine to produce mmBCFA acyl-CoA primers branched-chain 
aminotransferase (BCAT) and the branched-chain α-keto-acid dehydrogenase (BCKAD) 
complex (Oku and Kaneda 1988). The elongation of the mmBCFA backbone is then carried 
out by fatty acid synthase (FAS) (Oku and Kaneda 1988). C. elegans elongases elo-5 and elo-
6 (Kniazeva et al., 2004), as well as 3-ketoacyl-CoA reductase let-767 (Entchev et al., 2008) 
use C13ISO as a substrate to produce C15ISO and C17ISO. Inhibition of the endogenous 
production of mmBCFAs results in various developmental defects in the intestine and 
gonads, as well as defects in egg laying in the first affected (P0) generation, with progeny 
(F1) arresting at the L1 stage (Kniazeva et al. 2004). Furthermore, C17ISO has been shown 
to act in parallel with the insulin pathway as a developmental signal that nutrition is 
adequate for larval progression (Kniazeva et al., 2008).   
 
2.2.1.3. Polyunsaturated fatty acids 
Unlike plants and mammals, C. elegans possesses all the desaturase and elongase activities 
to synthesize arachidonic acid (AA, 20:4n6) and eicosapentaenoic acid (EPA, 20:5n3) from 
saturated fatty acid precursors (Watts and Browse, 2002). 
Specificity in the synthesis of fatty acids is usually achieved at the level of elongases. 
While ELO-5 and ELO-6 are involved in mmBCFA elongation, the elongases ELO-1 and 
ELO-2 function in concordance, providing worms with the necessary amounts of PUFA. 
ELO-1 elongates GLA (18:3n6) and SDA (18:4n3) to DGLA (20:3n6) and ETA (20:4n3), 
respectively. Still, in the elo-1 mutant GLA and SDA accumulate and PUFA elongation is 
reduced, but it is not completely devoid of C20 PUFAs (Watts and Browse, 2002) 
suggesting that another elongase, most likely ELO-2 (Benatti, et al., 2004) acts redundantly 
on C18 PUFAs. ELO-2 also utilizes C16:0 as a substrate in the first step of long chain FA 
elongation, and unlike the elo-1 mutant, which appears wild type, suppression of elo-2 
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causes multiple defects on an organismic level - in growth, reproduction, and 
physiological rhythms (Kniazeva et al., 2003).  
LET-767 (3-ketoacyl-CoA reductase) supposedly works in the second step of elongation 
process of both even-numbered LCFA and mmBCFA (Entchev et al., 2008). RNAi 
phenotypes of elo-5 and elo-6, let-767 RNAi larvae also undergo developmental arrest, that 
is suggested to follow from perturbed energy storage, insufficient quantities, and the 
altered molecular profile of basic cellular lipids, such as sphingolipids (Entchev et al., 
2008).  
There are nine elongase genes in the C. elegans genome, but apart from those mentioned 
here, there is not much known about the substrate specificity of the rest. Unlike mammals, 
C. elegans lacks the ability to elongate C20 PUFAs, resulting in the biosynthetic pathway 
ending with EPA (20:5n3).   
 C. elegans has three Δ9 desaturase genes designated fat-5, fat-6 and fat-7, encoding the 
enzymes necessary for the insertion of a double bond into a saturated fatty acid at the C9 
position. While the latter two of them (fat-6 and fat-7) display typical stearyl-CoA 
desaturate substrate preference, fat-5 prefers 16:0 and other medium chain fatty acids and 
has only limited activity on stearic acid (18:0) (Watts and Browse, 2000). cis-Vaccenic acid 
(18:1n7) is the most abundant fatty acid in C. elegans phospholipids and triacylglycrols 
(Tanaka et al., 1996), Watts and Browse suggest, that fat-5 is responsible for preservation of 
the optimal SFA/MUFA/PUFA ratio in cells by conversion of palmitic acid to cis-vaccenis 
acid (Watts and Browse, 2000).  
The three Δ9 desaturase single mutants, fat-5, fat-6, and fat-7 display few differences from 
wild type when grown under standard growth conditions, whereas the fat-5;fat-6;fat-7 
triple mutant is unable to survive (Brock et al., 2006). This indicates that subtle changes in 
fatty acid composition have no apparent effect and that these desaturases are functionally 
redundant, but total depletion of endogenous MUFA production is lethal to worms. Worm 
SFA/MUFA ratio is shown to be regulated by nuclear hormone receptor nhr-80, that is 
responsible for Δ9-desaturase gene expression (Brock et al., 2006). 
It is noteworthy that stearyl-CoA desaturases fat-6 and fat-7 are capable of desaturating 
trans-vaccenic acid (t18:1n11)(Watts and Browse, 2000; Santora et al., 2000), resulting in 
formation of 18:2n9(cis)n11(trans) conjugated linoleic acid (CLA). CLA has been shown in 
a number of studies to have anti-cancer properties and play a role in lipid and 
carbohydrate metabolism (for recent review on CLA, see Hennessy et al., 2011). This 
substrate specificity of Δ9-desaturases might be explained by shape similarity of trans-
fatty acids to saturated fatty acids.  
Four other desaturase genes in C. elegans have been isolated, two of those are present only 
in some insects and nematodes: Δ12-desaturase (fat-2) enabling synthesis of essential fatty 
acid linoleic acid (LA) from oleic acid; and ω3-desaturase (fat-1) catalyzing the conversion 
of LA into α-linolenic acid (ALA).  
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Figure 1. Polyunsaturated fatty acid (PUFA) synthesis pathway in C. elegans 
 
 
Δ12-desaturase mutant worms are incapable to produce linoleic acid (18:2n6) from oleic 
acid (18:1n), thereby disrupting the whole PUFA synthesis pathway in worm and 
accumulating oleic acid nearly 10-fold above that found in WT. Still, some small amount 
of unusual PUFAs like 18:2n9, 18:2n7, and 20:2n9 can be produced by fat-2 mutants (Watts 
and Browse, 2002). The loss of normal PUFAs in fat-2 homozygotes causes many defects
including slow growth, abnormal body shape, sluggish movement, cuticle defects, and 
reduced brood size (Watts and Browse, 2002).  
ω-3-desaturase (FAT-1) has been shown to have more than one fatty acid substrate - in 
addition to conversion of LA to ALA, this enzyme is capable of converting some 20-carbon 
ω6 PUFAs (dihomo-γ-linolenic acid, DGLA) to corresponding ω3 fatty acid 
(eicoastatraenoic acid, ETA)(Spychalla et al., 1997; Watts and Browse, 2002). However, this 
enzyme has rather low activity towards 20 carbon PUFA substrates and is arguably not 
able to convert highly polyunsaturated ω6 20 carbon arachidonic acid (AA, 20:4n6) to 
eicosapentaenoid acid (EPA, 20:5n3) (Meesapyodsuk et al., 2000). Loss of fat-1 gene and 
hence all ω3 PUFAs doesn’t seem to affect the worms health, at least in laboratory 
conditions, to any significant extent, and there are no apparent defects in morphology, 
movement, or reproduction (Watts and Browse, 2002). 
Transgenic mammalian cell culture (Xia et al., 2005) and even transgenic mice (Kang et al., 
2004; Xia et al., 2006; Ji et al., 2009) expressing C. elegans fat-1 gene have been generated to 
study the effect of lower ω6/ω3 ratio on health. 
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Δ5-desaturase (FAT-4) adds a double bond to DGLA converting it to AA (Watts and 
Browse, 1999), which is the longest chain ω6 PUFA in the nematode lipidome. AA has an 
important role in mammalian cells as a lipid mediator, constituent of lipid rafts and 
precursor for synthesis of hormone-like eicosanoid molecules as well as enocannabinoids 
(Meves, 2008; Pike, 2002; Harizi et al., 2008). However, in C. elegans, mutations in fat-4 gene 
do not lead to significant phenotypic effects (Watts and Browse, 2002), throwing doubt 
upon essentiality of ω6 fatty acids in nematodes (again, at least in laboratory conditions). 
Interestingly, as both fat-1 and fat-4 single mutants seem perfectly normal and proficient in 
chemotaxis to all odours, the fat-1;fat-4 double mutants (i.e. strains lacking all ω3 PUFAs 
and AA) display defects in chemotaxis to standard dilutions of the AWA-sensed odors 
diacetyl and pyrazine (Kahn-Kirby et al., 2004). This suggests that any one of the C20 
PUFAs, AA, EPA or eicosatetraenoic acid (20:4n3; also referred as ω3 arachidonic acid, 
O3AA) is required for AWA neuron mediated olfaction. Also, both fat-4 and fat-1 mutants 
are more sensitive to di-homo-γ-linolenic acid (DGLA, 20:3n6) than wild types and fat-
1;fat-4 double mutant is extremely sensitive (Watts and Browse, 2006). While most PUFAs 
do not affect the fertility of the nematodes, dietary supplementation and subsequent 
incorporation of DGLA causes sterility in C. elegans. This could be explained by the fact 
that fat-1 and fat-4 mutant strains are incapable of converting DGLA to other PUFAs, 
eicosatetraeniooc acid (ETA, 20:4n3) and arachidonic acid (AA, 20:4n6), respectively, and 
DGLA would accumulate in membranes of these worms. However, on unsupplemented 
plates double mutant strain accumulates approximately 22% DGLA, yet shows only low 
sterility (3%) (Watts and Browse, 2006). It is not clear why the germ line is protected from 
excess endogenously produced DGLA in the fat-1;fat-4 double mutant. 
In the same gene cluster with fat-4, the downstream fat-3 gene encodes Δ6-desaturase, the 
rate-limiting enzyme in PUFA synthesis that converts LA and ALA to γ-linoleic acid 
(GLA, 18:3n6) and stearidonic acid (SDA, 18:4n3)(Watts and Browse, 1999; Watts and 
Browse, 2002). The FAT-3 protein is expressed in the intestine, body-wall muscles, 
pharynx and several neurons (Watts et al., 2003). Although fat-3 mutants cannot produce 
any PUFAs, they are still viable and fertile with no apparent tissue or cell fate specification 
defects; they undergo normal neuronal development and display normal neuronal 
morphology (Watts et al., 2003; Lesa et al., 2003). There are also no significant changes in 
life span (Watts et al., 2003) and fat-3(wa22) mutants have in fact been shown to be more 
tolerant to extreme temperatures than wild type (Nandakumar and Tan, 2008). Still, the 
development rate from egg to adult hermaphrodite is about one day slower at 20°C and 
also the brood size is smaller (by about a hundred) than wild type (Watts et al., 2003; inII). 
The difference in number of eggs laid appears to be even larger at restrictive temperatures, 
also, one fifth of the embryos do not hatch at 15°C (Watts et al., 2003). In addition, lack of 
PUFAs in those mutants seems to lead to neuromuscular defects. The body-wall muscles 
used for locomotion seem to be affected as the fat-3 worms, although being capable of 
movement in response to touch, seem slightly uncoordinated showing straight body 
posture and less spontaneous movement (Watts et al., 2003). Their pharyngeal pumping 
rate is reduced to 70% of that of wild type and enteric muscle contraction fails in 31% of 
defecation cycles in fat-3 mutant animals (Watts et al., 2003). Although fat-3 mutants lay 
eggs at approximately half the rate of wild type, the newly laid eggs are in the same 
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developmental stage as those laid by wild type, suggesting that vulval and uterine 
muscles are probably not affected by lack of PUFA (Watts et al., 2003). Neuromuscular 
defects in fat-3 mutant worms can be explained by defects in neurotransmitter release at 
cholinergic and serotonergic neuromuscular junctions (NMJs). Lesa and colleagues (Lesa 
et al., 2003) demonstrated that that animals lacking LC-PUFAs release abnormally low 
levels of neurotransmitter and are severely depleted of synaptic vesicles. They also 
showed that these are not developmental but functional defects: mutant adults can be 
rescued by supplementing growth medium with exogenous LC-PUFAs. Furthermore, 
expression of fat-3 specifically only in neurons is sufficient to restore normal egg-laying 
and near-normal motility (Lesa et al., 2003).  
In a later study by Marza and colleagues (Marza et al., 2008) suggest that FAT-3 functions 
in the endocytic part of the synaptic vesicle recycling process. The decrease in 
neurotransmitter release caused by depletion of synaptic vesicles in fat-3 mutants was 
explained by depletion of synaptojanin (unc-26) at synapses. Synaptojanin is involved in 
vesicle uncoating in neurons, it decreases the affinity of clathrin adaptor proteins for the 
synaptic vesicle membrane by dephosphorylation of phosphatidylinositol-4,5-
bisphosphate (Cremona and De Camilli, 2001; Wenk and De Camilli, 2004). Within 
presynaptic terminals, synaptojanin allows recycling of synaptic vesicles. Mutations in the 
unc-26 gene cause a depletion of synaptic vesicles at neuromuscular synapses because 
synaptic vesicle components cannot be efficiently retrieved from the presynaptic plasma 
membrane (Harris et al., 2000). Increased levels of LC-PUFAs attained by Δ6-desaturase 
action increase synaptojanin localization or stabilization at release sites (Marza et al., 
2008).  
The somewhat Dumpy (short and fat) body shape of fat-3 worms (average body length 
80% that of wild-type L4s) is presumably linked to defects in cuticle composition resulting 
from C20 PUFA deficiency. These mutants are also more sensitive to cuticle disruption by 
alkaline hypochlorite treatment (Watts et al., 2003).  
A study by Nandakumar and Tan (2008) revealed another role for worm Δ6-desaturase, 
they showed using C. elegans-Pseudomonas aeruginosa host-pathogen system, that intestinal 
PUFA synthesis mediated by FAT-3 is important in basal immunity. C. elegans uses both 
constitutive and inducible innate immunity system to fight off microbial infections at the 
epidermis and in the intestine (reviewed in Nicholas and Hodgkin, 2004; Schulenburg et 
al., 2004). At least four pathways have been shown to be involved in innate immunity in C. 
elegans, including a p38 mitogen-activated protein kinase (MAPK) pathway, the 
insulin/insulin-growth-factor-receptor (IGF-1) pathway, a transforming growth factor-β 
(TGFβ) pathway and a programmed cell death (PCD) pathway (Aballay and Ausubel, 
2001; Kim et al., 2002; Garsin et al., 2003; reviewed in Tan and Shapira, 2011). Nandakumar 
and Tan (2008) determined that it is lack of two specific 18-carbon PUFAs, γ-linolenic acid 
(GLA, 18:3n6) and stearidonic acid (SDA, 18:4n3) in intestine that makes fat-3(wa22) 
mutant worms significantly more susceptible to infection and this is caused by reduced 
basal p38 MAP kinase pathway activity. Mutants in p38 MAP kinase pathway, such as the 
p38 MAP kinase mutant pmk-1, show defects in the constitutive expression of lysozymes, 
lectins and other effector molecules (Troemel et al., 2006). Under normal growth 
conditions, p38 MAP pathway is active as low levels of phosphorylated PMK-1 can be 
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detected. Depletion of GLA and SDA in the fat-3(wa22) mutant significantly reduced the 
levels of phosphorylated PMK-1, which further resulted in the altered basal expression of 
a number of immunity genes, as well as an increased susceptibility to oxidative stress 
(Nandakumar and Tan, 2008). The mechanism by which GLA and SDA affect the activity 
of p38 MAP kinase signaling and immune gene expression is currently unknown. 
The proper balance of PUFAs has also been shown to be a prerequisite for optimal egg 
production in C. elegans - DGLA (20:3n-6) supplementation leads to sterility caused by 
degeneration of germ cells during larval development, and induces excess programmed 
cell death in germ cells of adult animals (Watts and Browse, 2006). While the mutant 
strains for fat-1 (omega-3-desaturase) and fat-4 (delta-5-desaturase)  responsible for 20:4n3 
and AA production, respectively, are even more sensitive to DGLA induced sterility, 
strains deficient in the production of DGLA like fat-3 as well as elo-1 (GLA to DGLA 
elongase) mutants are more resistant to this DGLA effect (Watts and Browse, 2006).  
 
2.2.1.4. Cholesterol 
One major difference between nematode and mammalian lipid metabolism is the worms 
inability to de novo synthesize sterols - C. elegans has to gain sterols from environment 
(Hieb and Rothstein, 1968 ), from animal feces or yeast/plant remnants mostly through 
ingestion and absorption by the intestine (Matyash et al., 2001). This makes the worm an 
excellent model organism to investigate the distribution and function of sterols in a living 
organism as sterols can be replaced with fluorescent (dehydroergosterol, DHE) or 
photochemically reactive analogs. Besides cholesterol, other sterols (e.g. ergosterol, 
sitosterol, or their close precursors) can fully support worm growth (Wüstner et al., 2010). 
In vivo DHE labeling experiments show most prominent accumulation is in the pharynx, 
nerve ring, excretory gland cell, gut, and germ-line cells (Matyash et al., 2001; Wüstner et 
al., 2010). Enrichment of cholesterol in the apical surface of the pharynx and intestine may 
be needed to make it rigid or resistant to harsh environmental conditions in the lumen 
(Matyash et al., 2001). It has been suggested that nematodes regulate membrane fluidity 
through a sterol regulatory element binding protein (SREBP)-mediated transcriptional 
program that produces phosphatidylethanolamide, like in another cholesterol auxotroph 
Drosophila melanogaster (Seegmiller et al., 2002).  
As the amount of cholesterol acquired is too minute for it to have a major role as a 
modifier of membrane structure, it has been suggested to act mainly as a precursor of 
sterol-based hormones, metabolites that regulate transcription through nuclear receptors 
(Merris et al., 2003; Entchev and Kurzchalia, 2005). Cholesterol is known to be extensively 
metabolized by C. elegans to form several other sterols including 4α-methylated sterols 
(Chitwood, 1999; Merris et al., 2003). Cholesterol-derived hormones, the dafachronic acids, 
ligands for the hormonal receptor DAF-12, play a major role in controlling the life cycle 
and initiating dauer larva formation (Entchev and Kurzchalia, 2005; Martin et al., 2010) 
 
2.2.2. Lipid storage 
 
One of the several differences in C. elegans lipid metabolism compared to that of mammals 
is that nematodes lack mesoderm-derived adipose cells and store fat primarily in their 
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intestinal and skin-like epidermal cells. These cells express a variety of lipid biosynthetic 
and degradation enzymes (Ashrafi, 2007; Srinivasan et al., 2008; McGhee et al., 2007, 
McKay et al., 2003) and are also responsible for secretion of digestive lipases and 
peptidases (McGhee et al., 2007; Tcherepanova et al., 2000).  
Mutations or RNAi-mediated inactivation of C. elegans counterparts of many genes that 
encode various lipid biosynthetic pathways or their transcriptional regulators have 
previously been studied using lipid staining dyes like Nile Red, Sudan Black, Oil Red O 
and fluorescently labeled fatty acids (e.g. BODIPY)(Greer et al., 2008; Mukhopadhyay et 
al., 2005; McKay et al., 2003; Ashrafi et al., 2003; Brock et al., 2007; Kimura et al., 1997; Ogg 
et al.,1997) and shown to display either increased or reduced fat storing capability.  
Staining with dyes has its disadvantages: variable fixation and therefore variability with 
quantification with Sudan Black staining for example. Nile Red can be used for staining 
live worms, however fat stored outside of lysosome-related gut granules, like epidermal 
fat, cannot be readily visualized (O´Rourke et al., 2009; Watts, 2009). Epidermal fat is 
detectable by BODIPY staining; still it has shown some contradictory results in some 
mutants (Soukas et al., 2009). A new method to monitor C. elegans lipid stores is the 
coherent anti-Stokes Raman scattering (CARS) microscopy (Hellerer et al., 2007) which 
allows visualization of both epidermal and gut granule fat stores without the need for 
invasive techniques such as fixation or dependence on fluorescent reporters.  
It is not known whether intestinal and epidermal cells rely on different subcellular 
mechanisms for fat storage. The intestinal gut granules are lysosome-related, terminal 
endocytic compartments that have a lipid bi-layer, are acidified and contain a vacuolar 
proton pump (Clokey and Jacobson, 1986; Schroeder et al., 2007). Still, mutants with no 
gut granules have relatively normal triacylglyceride content and developmental rates, 
suggesting that loss of this compartment does not eliminate lipid storage (Schroeder et al., 
2007). One possibility is that the lysosome related organelles contain dietary fats taken up 
by intestinal cells. Epidermal cells do not contain such granules. While a number of gene 
inactivations have been identified that alter C. elegans fat content, the molecular 
mechanisms that underlie biogenesis of droplet-like fat stores and regulation of their size, 
number, and distribution are largely unknown. 
 
2.2.3. Regulation of fatty acid metabolism  
 
Many core metabolic pathways as well as fundamental pathways of food intake, digestion, 
and signaling found in mammals are well conserved in nematodes (Ashrafi, 2006; de Bono 
and Maricq, 2005; McKay et al., 2003; Ogg et al., 1997; Van Gilst et al., 2005b). C. elegans 
provides an excellent model for metabolic and neuro-endocrine regulation of lipid 
accumulation and energy homeostasis in the whole organism as worms are amenable to 
approaches like mutational and reverse genetic analysis, cell-specific expression studies 
and a variety of “-omics”.  
C. elegans respond to starvation with behavioral changes like reduction in feeding rate, 
measured by the number of pharyngeal muscle contraction-relaxation cycles (Avery and 
Horvitz, 1990), retention of eggs (Schafer, 2005), reduction in mating activity with males 
(Lipton et al., 2004), and initiation of various foraging behaviors (You et al., 2008; Hills et 
  
17
al., 2004; Sawin et al., 2000). Food depletion or dietary change also give rise to alterations 
in expression of fat metabolic genes (Taubert et al., 2006; Van Gilst et al., 2005a; Van Gilst 
et al., 2005b), composition of fat stores (Brock et al., 2007; Van Gilst et al., 2005a), and 
depletion of fat reservoirs (McKay et al., 2003). 
Pathways influencing fat storage and fat utilization are in C. elegans, as in mammals, 
regulated by a variety of complex transcriptional, translational and post-translational 
mechanisms (reviewed in Ashrafi, 2007). C. elegans fat reservoirs, which are stored in 
intestinal and skin-like epidermal cells (Ashrafi, 2006; Kimura et al., 1997), are regulated 
through insulin and some other neuroendocrine and transcriptional regulators of 
metabolic pathways that are also conserved in mammals (McKay et al., 2003, Ogg et al., 
1997; Van Gilst et al., 2005b).  
 
2.2.3.1. Sensory signaling in response to nutritional cues 
Serotonin (5-HT) signaling in worms has been shown to be required for mating and egg-
laying (Loer and Kenyon, 1993, Sze et al., 2000; Waggoner et al., 1998), enhanced slowing 
response (worms slow down their crawling velocity in the presence of food) associated 
with the re-exposure of food-deprived animals to food (Horvitz et al., 1982; Loer and 
Kenyon, 1993; Sawin et al., 2000), as well as experience-dependent choices in selecting 
growth-promoting bacteria and in avoiding pathogens (Shtonda and Avery, 2006; Zhang 
et al., 2005). Exogenous serotonin increases feeding rate, but decreases fat stores, 
indicating that serotonergic regulation of fat storage seems to be independent of feeding 
(Srnivasan et al., 2008). Neural 5-HT signaling mechanism responsible for fat reduction 
functions through 5-HT-gated chloride channel encoded by mod-1 and the GPCR encoded 
by ser-6 by promoting lipid oxidation via select β-oxidation genes in the periphery 
(Srnivasan et al., 2008).  
C. elegans transforming growth factor β (TGFβ) homologue daf-7 functions as part of a 
signaling pathway together with TGFβ receptor I and II homologues daf-1 and daf-4, 
respectively, and worm Smad transcription factor daf-3 (Savage-Dunn, 2005). TGFβ 
signalling was shown to regulate energy-balance pathways that affect dauer larva entry 
and recovery in response to environmental conditions (Ren et al., 1996; Liu et al., 2004; 
Burnell et al., 2005; Shaw et al., 2007).   
Recently Greer and colleagues (Greer et al., 2008) showed, that besides its role in 
development, daf-7 signaling is also important in adult fat storage, reproduction, and 
feeding behavior. DAF-7 is expressed in ASI sensory neurons and regulates feeding and 
fat storage through signalling via RIC and RIM interneurons, whereas, in case of HT-5, 
regulation of fat storage is molecularly independent from regulation of feeding. 
Expression of the DAF-7 is upregulated during refeeding after fasting (Wang and Kim, 
2003). Down-regulation of daf-7, which reflects depleting nutrient conditions, causes build-
up of fat reservoirs despite reduced feeding rate, in fact, de novo fatty acid synthesis rates 
in daf-7 and daf-1 mutants are nearly three-fold higher than in wild-type. Under poor 
environmental conditions, DAF-3 activation in RIM and RIC leads to tyraminergic 
regulation of feeding via the SER-2 receptor on pharyngeal neurons and glutamatergic 
regulation of fat through MGL-1 and MGL-3 metabotropic receptors. Glutamate signaling, 
in turn, initiates other neural or hormonal signals that ultimately signal to sites of fat  
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Table 1. Neuroendocrine regulators of C. elegans fat storage and utilization.  
 
 
regulation to shift the balance between storage and utilization pathways (Greer et al., 
2008). 
Insulin is one of the major factors in regulation of food intake and adiposity in mammals 
(Anika et al., 1980; Woods and Porte, 1983) as well as in C. elegans (Kimura et al., 1997); 
and similarly to mammals (Biddinger and Kahn, 2006) insulin signaling in different C. 
elegans tissues contributes differentially to fat content (Wolkow et al., 2000). Neuronal 
activity of daf-16, a forkhead/HNF3-related transcription factor (Lin et al., 1997; Ogg et al., 
1997) regulated by DAF-2/insulin-like signal pathway, a homolog of the mammalian 
insulin/insulin growth factor IGF-1 signal pathway, is more important for dauer formation 
(lesser for life span) while intestinal expression is critical for life span regulation (Libina et 
al., 2003; Lin et al., 2001).  
In mammals, insulin/IGF-1 signaling regulates the energy production through the 
expression of genes involved in glycolysis, gluconeogenesis and β-oxidation (Nakae et al., 
2008). During starvation, FOXO and DAF-16 are localized mainly in the nuclei and are 
activated (Baumeister et al., 2006; Huang and Tindall, 2007). However, in nematodes 
starvation also induces β-oxidation (Taubert et al., 2006), but DAF-16 activation 
additionally leads to fat accumulation and suppression of lipolysis (Ashrafi et al., 2003; 
Murphy et al., 2003; Narbonne and Roy, 2009). Starvation induces both dauer formation 
and L1 arrest in worms through the insulin/DAF-2/DAF-16 signaling pathway, daf-16 
mutants have a defective-arrest phenotype, failing to arrest development and dying 
rapidly when starved (Gems et al. 1998; Pierce et al. 2001; Baugh and Sternberg 2006; 
Ligand Receptor(s) Target(s) Regulated 
process 
Physiological 
response 
Refernces 
5-HT MOD-1  
SER-6 
beta-
oxidation 
genes 
fat reduction 
(MOD-1) 
feeding rate 
(SER-6) 
mating, 
egg-laying, 
locomotion in 
response to food, 
pathogen 
avoidance 
Loer and Kenyon, 1993 
Horvitz et al., 1982 
Sze et al., 2000 
Waggoner et al., 1998 
Srinivasen et al., 2008 
Shtonda & Avery, 2006 
 Zhang et al., 2005 
DAF7/ 
TGFβ 
DAF-1 & -4  
DAF-3 /Smad 
Glu and  
Tyr  signaling 
 
fat storage 
 (MGL-1 & -3) 
feeding rate 
(SER-2)  
dauer larva entry 
and recovery 
Ren et al., 1996 
Wang & Kim, 2003 
Liu et al., 2004 
Burnell et al., 2005 
Savage-Dunn, 2005 
Shaw et al.,2007 
Greer et al., 2008 
insulin DAF-2/ 
DAF-16  
IL signaling 
pathway 
delta-9 
desaturases, 
elongases 
 
fat 
accumulation, 
de novo 
synthesis, 
suppression 
of lipolysis  
dauer larva entry,  
lifespan 
regulation, 
innate immunity 
Kimura et al., 1997  
Wolkow et al., 2000 
Libina et al., 2003  
Lin et al., 2001 
Ashrafi et al., 2003; 
Murphy et al., 2003 
Narbonne & Roy, 2009 
Perez & Van Gilst, 2008 
You et al., 2008  
Horikawa & Sakamoto, 
2010 
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Fukuyama et al. 2006). You and coworkers determined the role of insulin signaling in 
quiescence, a worm behavior compatible to satiety in other animals (You et al., 2008).  
Perez and Van Gilst showed that the predominant mechanism by which the insulin 
signaling pathway affects fat storage in C. elegans is de novo synthesis (Perez and Van Gilst, 
2008). The well studied daf-2(e1370) allele blocks insulin signaling, extends life span, and 
leads to elevated fat accumulation. However, they noticed that some daf-2 mutations 
activate DAF-16 capacity to promote longevity but not de novo lipogenesis, and suggested 
that differential modification of daf-16 is required for its impact on lipogenesis, because of 
tissue-specific differences in the signaling mechanism, or because daf-16 control of 
lipogenesis may be more sensitive to signaling dosage (Perez and Van Gilst, 2008). Using a 
RNAi approach on genes involved in PUFA synthesis, Horikawa and Sakamoto (2010) 
demonstrated that daf-16 is regulated under the control of fatty acid metabolism, and that 
daf-16 itself is involved in the maintenance of fatty acid homeostasis as well as regulation 
of TAG levels. The authors propose a hypothetical model of how DAF-16 regulates PUFA 
synthesis by upregulating mRNA expression of fatty acid desaturases and elongases, 
whereas PUFA has a suppressive effect on nuclear localization and transcriptional activity 
of DAF-16 (Horikawa and Sakamoto, 2010). 
 
2.2.3.2. Transcriptional regulation of adiposity 
Besides DAF-16/FOXO and DAF-3/SMAD there are many other transcription factors 
found in both nematodes and mammals that are involved in fat storage and metabolism 
(Table 2). PolII-dependent transcription relies on transcriptional co-regulators like 
Mediator, a multisubunit complex that is targeted by many transcriptional regulatory 
factors. Whereas some of the Mediator complex subunits are required for essentially all 
PolII-driven transcription (Shim et al., 2002), others influence specific physiological and/or 
developmental processes (Wang et al., 2004). Mediator complex has been established as an 
essential coactivator for a broad range of nuclear hormone receptors (NHRs) as well as 
several other types of gene-specific transcriptional activators. Nonsteroid NHRs, including 
the peroxisome proliferator-activated receptors PPARα, PPARβ/δ, and PPARγ, function as 
sensors for fatty acids and fatty acid derivatives, regulating fat, glucose, and cholesterol 
homeostasis (reviewed in Desvergne and Wahli 1999). 
C. elegans Mediator subunit MDT-15 acts as coactivator of NHR-49 (Taubert et al., 2006) 
and has been shown to interact with NHR-64 ligand binding domain (LBD) (Liang et al., 
2010). NHR-49 functionally resembles human PPARα: like PPARα it controls glycolysis, 
gluconeogenesis, lipid synthesis, fatty acid β-oxidation and Δ9-desaturation (Nakamura et 
al. 2004; Van Gilst et al., 2005a; Van Gilst et al., 2005b, Atherton et al., 2008). MDT-15 
coactivation of NHR-49 is necessary for elevation of mRNA levels of genes for β-oxidation 
(acs-2, acs-11, hacd-1) and the glyoxylate cycle (gei-7) in response to short-term fasting. Two 
of thise genes, acs-2 and gei-7 depend on nhr-49 in both fed and fasting conditions, while 
hacd-1 and acs-11 do not require nhr-49 for induction in the fed state. NHR-49/MDT-15 also 
modulates Δ9-desaturation by activating expression of fat-5 and fat-7, whereas nhr-49 
activation of fat-7 is relieved or actively inhibited in fasted animals leading to 
accumulation of SA (Van Gilst et al. 2005a, Van Gilst et al. 2005b). Increased OA 
production caused by fat-7 activity, in turn leads to inhibition of the same β-oxidation  
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Table 2. Transcription factors known to be involved in regulation of fatty acid biosynthesis and 
energy homeostasis in C. elegans.  
 
 
genes induced by nhr- 49 (Van Gilst et al. 2005a). 
Nuclear hormone factor gene nhr-80 is proposed to be derived from the same ancestral 
gene as nhr-49, related to the mammalian gene encoding hepatocyte nuclear factor 4 
(Robinson-Rechavi et al., 2005). Like nhr-49 mutant worms, nhr-80 mutants also show 
increased SA content as compared with wild-type worms; but apart from nhr-49, they 
display no increase in overall fat storage or triglyceride synthesis (Brock et al., 2006). Aslo,  
nhr-80 mutants do not have a shortened lifespan. Milder phenotype of nhr-80 
mutants//RNAi as well as nhr-49 QPCR results (Van Gilst et al., 2005a) suggest that NHR-
80 specifically regulates Δ9-desaturase levels, while NHR-49 appears to regulate a wider 
range of lipid homeostasis pathways. 
 In mammals C/EBP (CCAAT/enhancer-binding protein) and sterol-regulatory-element-
binding protein (SREBP) regulate the expression of a number of lipogenic enzymes, 
including acetyl coenzyme A carboxylase (ACC), ATP-citrate lyase (ACL), fatty acid 
synthase (FAS), glycerol 3-phosphate acyltransferase (G3PA), and malic enzyme (MA) 
(Christy et al., 1989; Kim and Spiegelman, 1996; Shimano et al., 1999). McKay and 
colleagues (2003) showed that C. elegans homologues lpd-2 and sbp-1 (lpd-1), respectively, 
Transcription 
factor 
Pathway/co-
regulator 
Regulated process Reference 
NHR-49 MDT-15 beta-oxidation (acs-2, acs-11, hacd-1) 
glyoxylation (gei-7) 
delta-9 desaturation (fat-5, fat-7) 
Atherton et al., 2008 
Nakamura et al., 2004 
Taubert et al., 2006 
Van Gilst et al., 2005a 
Van Gilst et al., 2005b 
NHR-80  delta-9  desaturation  Brock et al., 2006 
SBP-1/SREBP - lipogenesis (pod-1/ACC, ACL, fasn-
1/FAS, G3PA, ME) 
McKay et al., 2003 
 
 MDT-15  delta-9 desaturation (fat-6, fat-7) 
 
Kamath et al., 2003 
Yang et al., 2006 
 CBP-1 (CBP/p300) mmBCFA synthesis  
elongation (elo-5, elo-6) 
Kniazeva et al., 2008 
 IRE-1 
HSP-4 
induction of fasting induced lipases 
(fil-1 and -2) 
Jo et al., 2009 
DAF-16/FOXO DAF-2 
(Insulin/IGF 
signalling) 
de novo synthesis : 
desaturation (fat-2, fat-6, fat-7) 
elongation (elo-2) 
CoA synthesis (pnk-1) 
glyoxylation (gei-7) 
gluconeogenesis (PEPCK ) 
lipid binding (lbp-7) 
acylCoA dehydrogenase(F54P5.7)  
Murphy et al., 2003 
Lee et al., 2003 
Oh et al., 2005 
Halaschek- Wiener et 
al., 2005 
Wang and Kim, 2003 
 
DAF-3 /Smad DAF-7/TGFβ 
signaling 
glutamate  signaling: 
fat storage (MGL-1 & -3) 
tyramine signaling: 
feeding rate (SER-2)  
Greer et al., 2008 
Wang and Kim, 2003 
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regulate the same lipogenic genes in the worm. It has been suggested that SREBP acts 
downstream of C/EBP in both mammals and worms (McKay et al., 2003)  
In addition to NHR-49, the Mediator subunit MDT-15 interacts directly and specifically 
with the activation domain of SBP-1 (McKay et al., 2003; Yang et al., 2006). RNAi of either 
mdt-15 or sbp-1 revealed a decrease in TAG levels as well as qualitative changes in the 
ratios of different fatty acids -increased SA and decreased OA levels (Yang et al., 2006). 
This leads to growth defects, infertility, aberrant locomotion, decreased lifespan and 
transparent or ‘clear’ phenotype, resembling starved C. elegans deprived of nutrients 
(Kamath et al. 2003). Dietary supplementation with oleic acid rescues these phenotypes. 
These results suggest that SPB-1/MDT-15 complex regulates SA/OA ratio by maintenance 
of normal fat-6 and fat-7 mRNA levels (Yang et al., 2006).  
sbp-1 has also been shown to regulate mmBCFA biosynthesis as well as the expressions of 
elo-5 and elo-6, but in an MDT-15-independent manner (Kniazeva et al. 2008). A short 
sequence within the amino-terminal activation domain of SREBP-1a binds both 
ARC/Mediator co-activator and the chromatin-targeting CBP/p300 acetyltransferase (Näär 
et al., 1999; Oliner et al., 1996; Toth et al, 2004). C. elegans CBP/p300 homolog cbp-1, has 
recently been shown to collaborate with SBP-1 in regulating mmBCFA biosynthesis 
(Kniazeva et al., 2008). Also, together with IRE-1 (an ER protein known to be involved in 
the unfolded protein response) and HSP-4 (an ER-resident molecular chaperone, BiP), 
SBP-1 and CBP-1 are required for induction of two genes that encode presumed TG 
hydrolases named fil-1 and fil-2 (for fasting-induced lipase-1 and -2, respectively) upon 
fasting (Jo et al., 2009). However it is yet unclear whether it is a direct regulation of fil-1 
and fil-2 transcription and whether sbp-1 and cbp-1 act downstream of ire-1 and hsp-4 in 
fasting-induced lipase gene activation.  
 
 
2.3. ENDOCANNABINOID SYSTEM 
 
2.3.1. History of endocannabinoid system  
 
The endocannabinoid system (ECS) takes its name from the cannabis plant (Cannabis 
sativa), an annual herb also known as hemp. Marijuana and other derivatives of the plant 
Cannabis sativa have been used for thousands of years for their therapeutic and mood-
altering properties. To date, three types of cannabimimetic compounds have been 
described: herbal cannabinoids, which occur uniquely in the cannabis plant; endogenous 
cannabinoids (or endocannabinoids), which are produced in the brain and peripheral 
tissues; and synthetic cannabinoids, which have been developed by drug companies as 
potential pain medications. 
Δ9-Tetrahydrocannabinol (Δ9-THC) was identified as the major psychoactive component 
of cannabis in 1964 (Gaoni and Mechoulam, 1964). Its cellular target, the cannabinoid 
receptor type 1 (CB1R), was characterized and cloned more than two decades later 
(Devane et al., 1988; Herkenham et al., 1991; Matsuda et al., 1990). Shortly after that, in 
1993, a second mammalian cannabinoid receptor type 2 (CB2R), was characterized (Munro 
et al., 1993). They are both G protein-coupled seven transmembrane domain receptors and 
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differ in their tissue distributions. The CB1R is abundantly expressed in the central 
nervous system (CNS), whereas the CB2R is present mainly in the immune system.  
A number of biologically active analogs of Δ9-THC have been synthesized. These 
compounds are collectively called cannabinoids because of their cannabimimetic actions 
and have been used for laboratory animals to produce various behavioral symptoms 
analogous to those in humans (Howlett, 1995). The discovery of the cannabinoid receptor 
and the availability of highly selective and potent cannabimimetics led to the rapid 
identification of a family of lipid transmitters that serve as natural ligands for the CB1R. 
Anandamide (N-arachidonyl-ethanolamide) was the first endocannabinoid discovered in 
1992 by screening porcine brain extracts for compounds that bound to the cannabinoid 
receptor (Devane et al., 1992). It was later shown that anandamide could stimulate 
cannabinoid receptor-mediated signal transduction (Felder et al., 1993). The second 
endocannabinoid identified was 2-arachidonoyl glycerol (2-AG), which was isolated from 
canine gut and shown to have in vivo effects similar to Δ9-THC (Mechoulam et al., 1995). 
 
2.3.2. Endocannabinoid signaling molecules 
 
The endocannabinoid system has raised much interest in the last decade because of the 
pleiotropic biological effects ascribed to this complex network. This consists of: (1) 
endocannabinoids, of which AEA and 2-AG are the best known; (2) receptors, through 
which endocannabinoids elicit their physiological functions; (3) proteins and enzymes for 
the regulation of endocannabinoid levels and action at receptors; and (4) a putative 
membrane transport system (De Petrocellis et al., 2000).  
 
2.3.2.1. Endocannabinoids and other endogenous cannabimimetics 
Endocannabinoids (ECs) are a class of lipid mediators found in several tissues and based 
on a polyunsaturated fatty acid amide or ester motifs (for review see Oz, 2006). There are 
two major classes of endocannabinoids – acylethanolamines and acyl-glycerols (esters of 
glycerol and fatty acids), with AEA and 2-AG as most prominent representatives, 
respectively. In addition, there is a third class of endogenous lipid molecules, called N-
acyldopamines that have been shown to activate transient receptor potential vanilloid type 
1 receptor (TRPV1). However two of these “endovanilloids“, N-arachidonoyl-dopamine 
(NADA) and N-oleoydopamine (OLDA), are capable of activating cannabinoid receptor 1. 
Furthermore, recently there have been indications of a few hemoglobin-derived peptides 
that act as CB1R agonists (Gomes et al., 2009). 
 
N-acylethanolamines (NAEs) contain an ethanolamide group linked to an acyl group that 
varies in length and saturation. The most well-studied NAE, arachidonoyl-ethanolamide 
(AEA) has, as inferred from the designation, arachidonic acid (20:4n6) as the acyl group. 
The common name for AEA, anandamide is taken from the Sanskrit word ananda, which 
means "bliss, delight".  
Since its discovery, AEA has been implicated in many physiological processes such as 
memory (Terranova et al., 1995), immunity (for overview on ECS and immune system see 
Tanasescu and Constantinescu, 2010), anxiety (Kathuria et al., 2003), pain modulation 
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(Walker et al., 1999; Cravatt et al., 2004; Petrosino et al., 2007; for review on ECS and pain 
see Guindon and Hohmann, 2009), feeding behaviour (reviewed in Capasso and Izzo, 
2008; Hansen and Diep, 2009), male and female fertility (reviewed in Wang et al., 2006; 
Battista et al., 2008), vasorelaxation (Kunos et al., 2002; Mukhopadhyay et al., 2002), 
hypotension and bradycardia (reviewed in Kunos et al., 2000, Kunos et al., 2002). 
Noteworthy is the ability of AEA to regulate neural progenitor proliferation and 
differentiation, neuritogenesis, axonal growth and synaptogenesis (reviewed by Galve-
Roperh et al., 2006).  
Anandamide behaves as a partial agonist at both type 1 and 2 cannabinoid receptors 
(Sugiura et al., 2002), transient receptor potential vanilloid type 1 (TRPV1; Zygmunt et al., 
1999), the nuclear receptor peroxisome proliferator- activating receptor-alpha (PPARα; Sun 
et al., 2007) and -gamma (PPARγ; Bouaboula et al., 2005) and, according to some studies, 
GPR-55 (Lauckner et al., 2008; Ryberg et al., 2007). In addition, AEA has been shown to 
inhibit several voltage-gated ion channels including Ca2+ channels, Na+ channels, various 
types of K+ channels, and ligand-gated ion channels such as serotonin type 3, nicotinic 
acetylcholine, and glycine receptors (for review see Oz, 2006). Cholesterol is able to bind 
AEA, presumably by interacting with the more extended part of the acyl chain (Biswas et 
al., 2003). Although AEA has been shown to exhibit a variety of cannabimimetic activities 
in vitro and in vivo and despite to its strong binding activity toward the cannabinoid 
receptors, Sugiura in his review (Sugiura et al., 2006) questions the role of AEA as an 
effective ligand for those receptors. It has been shown that the level of anandamide in the 
fresh brain is very low (Sugiura et al., 1996; Schmid et al., 1995; Kempe et al., 1996; Felder 
at al., 1996). 
Besides AEA, additional bioactive N-acylethanolamines have been subsequently 
identified. These fatty acid-derived lipids are also produced in an activity-dependent 
manner, have distinct pharmacological profiles at CBRs and other receptor subtypes, and 
yet have remained largely unstudied. Other NAEs, like polyunsaturated homo-gamma-
linolenoyl- (HEA), docosatetraenoyl- (DEA), eicosatrienoyl-, eicosapentaenoyl-, and 
docosahexaenoyl ethanolamide can also bind to the CB1R, although with lower affinity 
than anandamide (Hanus et al., 1993; Sheskin et al., 1997). Monounsaturated oleoyl 
ethanolamide (OEA) and saturated palmitoyl ethanolamide (PEA) and stearoyl 
ethanolamide (SEA) are considered as cannabinoid receptor-inactive NAEs, however, 
they are still regarded as cannabinoids by many researchers and hypothesized to possess 
cannabimimetic activity possibly due to entourage effects. According to this theory, other 
NAEs may increase anandamide levels in tissues by competing with this compound for 
FAAH-mediated hydrolysis, resulting in a potentiation of anandamide's actions on 
cannabinoid or/and vanilloid receptors (Smart et al., 2002; Ho et al., 2008).  
In addition to plants and mammals, NAEs have also been identified in fish (Natarajan et 
al., 1985), invertebrates such as sea urchins and mollusks (Bisogno et al., 1997 and Sepe et 
al., 1998), and in certain microorganisms such as Butyrivibrio sp. (Clarke et al., 1976) and 
slime molds (Ellingson, 1980). 
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Figure 2. Major classes of endocannabinoid-like molecules (R marks fatty acyl moiety) and 
their arachidonic acid derived representatives.  
 
O-Arachidonoyl ethanolamine is another acyl-ethanolamine, but in this case arachidonic 
acid and ethanolamine joined by an ester linkage, the opposite of the amide linkage found 
in anandamide. Based on this opposite orientation, the molecule was named virodhamine,  
from the Sanskrit word virodha, which means opposition. The concentration of 
virodhamine in peripheral tissues is two- to nine fold higher than that of anandamide and 
acts as a partial agonist at the CB1R and a full agonist at the CB2R (Porter et al., 2002).  
Four long-chain fatty acid dopamines have been identified in nervous bovine and rat 
tissues. Two unsaturated members of this family of lipids, N-arachidonoyl-dopamine 
(NADA) and N-oleoyl-dopamine (OLDA), have been identified as a new class of brain 
neurotransmitters that potently activate the transient receptor potential channel type V1 
(TRPV1, also known as the vanilloid receptor type 1 for capsaicin) (De Petrocellis et al. 
2004). NADA activates the CB1R with affinity similar (nano-molar) range to that of AEA 
(Bisogno et al. 2000), thereby sharing endocannabinoid and endovanilloid biological 
activities. Compared with AEA, NADA is more potent at TRPV1 and less potent but more 
efficacious at CB1R (Bisogno et al, 2000; Bezuglov et al, 2001; Huang et al, 2002). However, 
OLDA shows only a modest affinity for the CB1R (Chu et al., 2003) and the other two 
congeners, N-palmitoyl- and N-stearoyl-dopamine (PALDA and STEARDA), are inactive 
on CB1R and possess very low TRPV1 activity (Chu et al., 2003). 
 
2-arachidonolglycerol (2-AG) was the second endogenous cannabinoid receptor ligand to 
be found (Sugiura et al., 1995) and the most potent compound among a number of 
naturally occurring cannabimimetic molecules (Sugiura et al., 2000). Whereas anandamide 
(AEA) often acts as a partial agonist at cannabinoid receptors, 2-AG acts as a full agonist in 
most cases and it has been suggested that 2-AG rather than anandamide is the true natural 
ligand for both the CB1R and the CB2R (Sugiura et al., 2006). It is also much more 
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abundant than AEA - in the brain, the concentration of 2-AG is 200-fold higher than that of 
anandamide (Sugiura et al., 1995; Stella et al., 1997). 2 -AG is rapidly formed from 
arachidonic acid-containing phospholipids through increased phospholipid metabolism, 
such as enhanced inositol phospholipid turnover, in various tissues and cells upon 
stimulation. Despite its higher concentration, 2-AG has not obtained as much attention as 
AEA in ECS studies. One of the reasons might be that the binding activity of 2-AG 
reported in preceding studies may have been under-estimated because of possible 
degradation by hydrolyzing enzyme(s) during prolonged incubation (Sugiura et al., 1995), 
being metabolized rapidly by a monoacylglycerol lipase and/or an amidohydrolase in 
cultured cells (Di Marzo et al., 1998). 
An ether-type endocannabinoid molecule, 2-arachidonylglyceryl ether, also known as 
noladin ether, has been isolated from porcine (Hanus et al., 2001) and rat (Fezza et al., 
2002) brain. However, later findings were rather contradictory; Oka and coworkers (Oka 
et al., 2003) demonstrated that NE might not be present at detectable levels in the brain. 
NE has been demonstrated to bind both CB1R (Steffens et al., 2005) and CB2R (Shoemaker 
et al., 2005) and to act as partial agonist for the TRPV1 (Duncan et al., 2004). Although 
much more chemically stable than 2-AG, with an endogenous half-life of hours rather than 
minutes (Laine et al., 2002), noladin ether is claimed to be at least 10-fold less potent 
(Hanus et al., 2001). 
Hemopressin (Hp), a 9-residue α -hemoglobin-derived peptide, was reported by Heimann 
and colleagues to function as a CB1R antagonist (Heimann et al., 2007). Recently, N-
terminally extended forms of Hp containing either three (RVD-Hpα) or two (VD-Hpα) 
additional amino acids were identified, as well as a β–hemoglobin-derived peptide with 
sequence similarity to that of hemopressin (VD-Hpβ) (Gomes et al., 2009). N-terminally-
extended forms, however, act as CB1R agonists (Gomes et al., 2009). Still, it remains to be 
assured if Hp is truly an endogenous brain peptide or just an artifact of Asp-Pro bond 
cleavage of the longer (11- and 12-residue) peptides. 
 
2.3.2.2. Cannabinoid receptors 
To date, two G protein-coupled cannabinoid receptors have been identified by molecular 
cloning; these are the G protein coupled receptors (GPRCs) cannabinoid type 1 (CB1R) and 
type 2 (CB2R) receptor. The transient receptor potential vanilloid type 1 receptor (TRPV1) 
is activated by the naturally occurring vanilloids, capsaicin and resiniferatoxin (RTX), 
noxious heat and acid (see Szallasi, 2002), but is also considered to be a target for 
endocannabinoids (Zygmunt et al., 1999; Ralevic et al., 2001). In addition, two orphan 
GPCRs have emerged as candidate cannabinoid receptors: GPR-119, which is reportedly a 
receptor for OEA (Overton et al., 2006); and GPR-55, which is reportedly activated by 
various cannabinoids (Baker et al., 2006; Ryberg et al., 2007; for review see Shahir and 
Abood, 2010). Recent evidence also points to cannabinoids acting via members of the 
nuclear receptor family, peroxisome proliferator-activated receptors (PPARs, with three 
subtypes α, β and γ), which regulate cell differentiation and lipid metabolism (reviewed in 
O’Sullivan and Kendall, 2010).  
A further addition to the multiplicity of endocannabinoid action and targets is the 
detection of heteromers between CB1R and various other GPCRs, including adenosine 
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A2A, dopamine D2 and orexin 1 receptors (Kearn et al., 2005; Ellis et al., 2006; Carriba et 
al., 2007; Navarro et al., 2008).  
The complexity of the cannabinoid system and the identification of a number of non-
CB1R, non-CB2R targets for endocannabinoids have made conclusive evidence of 
molecular pathways stimulated by these molecules very difficult to achieve. 
Both CB1 and CB2 receptors belong to the large superfamily of G protein coupled 
receptors (GPCRs) that pass through cell membranes seven times (heptahelical receptors). 
Cannabinoid receptors (CBRs) contain an N-terminal extracellular domain that possesses 
glycosylation sites, a C-terminal intracellular domain coupled to a G protein complex, and 
7 hydrophobic transmembrane segments connected by alternating extracellular and 
intracellular loops. Three-dimensional models of the helix bundle arrangement of human, 
rat and mouse CB1R and CB2R have been constructed and compared (Bramblett et al., 
1995). 
As GPCRs, they are associated with G proteins of the Gi/o family (Gi1,2 and 3, and Go1 and 2) 
via the intracellular loops of the protein. While both receptors display a high affinity for 
Gi, the affinity of the CB1R for Go is ten fold higher than that of the CB2R (Glass and 
Northup, 1999). Furthermore, CB1R and CB2R do not couple identically to signal 
transduction pathways (reviewed in Pertwee, 1997; McAllister and Glass, 2002).  
The CB1 receptor is among the most highly expressed G protein–coupled receptors in the 
CNS (Herkenham et al. 1990) and mediates most of the neurobehavioral effects of 
cannabinoids, whereas CB2R is expressed by immune and hematopoietic tissues 
(reviewed by Ameri, 1999). The CB1R expression is very high in basal ganglia, cerebellum, 
hippocampus, and parts of olfactory cortex and is moderate to high in cerebral cortex, 
olfactory bulb, septum, amygdala, and a few brainstem nuclei (Herkenham et al. 1990; 
Tsou et al. 1997; reviewed in Freund et al. 2003), but it has also been found in a number of 
peripheral tissues, such as the cardiovascular and reproductive systems as well as the 
gastrointestinal tract (Croci et al., 1998, Pertwee, 1997, Pertwee, 2001: Wagner et al., 2001). 
On the other hand, CB2R has been detected also in the CNS, e.g., in the microglial cells 
(Ashton et al., 2007) as well as the neurons (Gong et al., 2006) (for review on structure and 
distribution of CB receptors see articles by Kano et al., 2009; Svízenská et al., 2008; 
Rodríguez de Fonseca et al., 2005; Pazos et al., 2005.) During CNS development, CB1R 
plays important roles in the regulation of dendritic branching, synapse density, and 
regulation of synaptic transmission (Vitalis et al., 2008; reviewed in Harkany et al., 2007). 
Some cannabinoid effects are not mediated by either type of CBRs, and in some cases there 
is compelling evidence to implicate additional receptors in these actions (Begg et al., 2005; 
Ryberg et al., 2007). The first indication that cannabinoid receptors other than CB1R or 
CB2R may exist came from studies of the mesenteric vasodilator effect of cannabinoids 
(for review of cardiovascular effect of cannabinoids see Randall et al., 2004). In the rat 
isolated perfused mesenteric arterial bed preparation, AEA and R-methanandamide elicit 
long-lasting vasodilation, whereas other endogenous (i.e., 2-AG, PEA) and synthetic 
cannabinoids potent at both CB1R and CB2R or THC do not have a dilator effect (Wagner 
et al., 1999). The vasodilatory responses of isolated arteries exposed to AEA were shown to 
be mediated through the transient receptor potential vanilloid type 1 receptor (TRPV1) 
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and involve the release of calcitonin-gene-related peptide (CGRP) from perivascular 
sensory nerves (Wagner et al., 1999). 
TRPV1, similar to other TRP channels, is a putative six-transmembrane-spanning non-
selective cation channel with a preference for calcium that is directly activated by 
capsaicin and noxious temperatures (Caterina et al., 1997). Besides its abundant expression 
in peripheral sensory efferents, as well as in trigeminal and dorsal root ganglia, 
particularly at the level of small, unmyelinated C-fibers (see Di Marzo et al., 2002 for a 
review) TRPV1 is also expressed in non-sensory tissue (Szallasi and Blumberg, 1999; 
Michael and Priestley, 1999; Mezey et al., 2000) and may mediate inflammatory rather 
than acute thermal pain. Also, TRPV1 might be activated not only by ligands but also 
through phosphorylation. Protein-kinase dependent phosphorylation of TRPV1 causes 
sensitization, whereas dephosphorylation by protein phosphatases promotes 
desensitization. (Premkumar and Ahern, 2000; Bhave et al., 2002; for review see Rohacs et 
al., 2008). 
Ryberg and colleagues demonstrated that various plant and synthetic cannabinoid ligands 
as well as endocannabinoids 2-AG, AEA and virodhamine activate GTPγS by binding to 
the orphan G-protein-coupled receptor, GPR-55 (Ryberg et al., 2007). The authors also 
reported that GPR-55 is activated by OEA and PEA which lack significant activity as CB1R 
or CB2R agonists. Furthermore, 2-AG, PEA and virodhamine displayed markedly greater 
potency as a GPR--55 agonist than a CBR agonist (Ryberg et al., 2007). Lauckner and 
coworkers found that GPR55 is activated by THC, AEA, methanandamide (MEA), 
JWH015, and lysophosphatidyl inositol (LPI) but not by other cannabinoids including CP, 
WIN, and 2-AG (Lauckner et al., 2008). Cannabinoid mediated activation of GPR-55 
inhibits potassium current through M-type potassium channels and releases calcium from 
IP3-sensitive ER stores. (Lauckner et al., 2008). However, later studies have disputed the 
binding ability of ECs to GPR-55 and the whole idea of GPR-55 as a potential cannabinoid 
receptor is currently under debate (see review about pharmacology of GPR-55 by Shahir 
and Abood, 2010). 
Another orphan receptor, GPR-119 was tested for its binding properties to ECs because of 
its remote sequence relationship to the cannabinoid receptors (Overton et al., 2006), 
Although anandamide exhibited only minimal activity at GPR-119, ethanolamides bearing 
less unsaturated fatty acid moieties showed superior activities, with OEA being the most 
efficacious agonist tested. The endovanilloid compounds NODA and structurally related 
hydroxybenzyl amides have recently been described as GPR-119 agonists with in vitro 
potencies similar to that of OEA (Chu et al., 2010). Still, all of these compounds activate 
GPR-119 at low micromolar potencies and it is currently unknown whether physiological 
activation of GPR-119 is mediated by 1) multiple lipid amides acting in cooperative 
fashion, 2) a particular low-potency lipid amide among those described here or 3) an 
undiscovered lipid with significantly greater potency toward GPR-119 (Chu et al., 2010). 
In addition to G-protein-coupled receptors (GPCR) and other plasma membrane receptors, 
another potential candidate for CB1R /CB2R -independent effects of cannabinoids is the 
peroxisome-proliferator-activated receptor (PPAR) nuclear receptor superfamily of 
ligand-activated transcription factors. 
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The three subtypes of PPARs (PPARα, PPARβ, and PPARγ) play important roles in 
regulation of lipid metabolism, hepatic peroxisomal enzyme expression, insulin 
sensitivity, glucose homeostasis, and inflammation. In addition to fatty acids and 
eicosanoids (Kliewer et al., 1997; Sun and Bennett, 2007), AEA, 2-AG and two non-CBRs 
agonists, OEA and PEA, are endogenous ligands for PPARs (reviewed in O’Sullivan, 
2007). 
Fu and colleagues have shown, that OEA induced  regulation of feeding behaviour in rats 
appears to be due to its activation on PPARα (Fu et al., 2003; Fu et al., 2005). AEA has been 
shown to directly activate PPARα (Sun et al., 2007), but it could also be metabolised 
(through both hydrolysis and oxidation) to other lipid mediators, which may be potential 
PPARs ligands. Sun and Bennet (Sun and Bennett, 2007) suggest in their review, that 
endocannabinoids, especially anandamide may instead activate retinoid X receptors 
(RXRs) that heterodimerize with PPARs.  
In the same systems, most endocannabinoids (OEA, AEA, noladin ether, and 
virodhamine) show similar binding and transcription activity on PPARα. Only the 
saturated NAE, PEA has no binding ability with PPARγ and PPARα in vitro, and seems to 
act through an indirect mechanism (Sun et al., 2007). 
Whereas PPARα functions in lipid catabolism and homeostasis in the liver, the PPARγ 
subtype appears to play a primary role in the storage of lipids in adipose tissue, being 
regarded as a very sensitive hallmark of adipocyte differentiation (reviewed in Gregoire et 
al., 1998). ECS has been reported to be present in adipose tissue, to interact with PPARγ 
and to induce 3T3–L1 preadipocyte differentiation (Gasperi et al., 2007; Bouaboula et al., 
2005; Pagano et al., 2007). Increase of PPARγ expression during adipocyte differentiation 
process is apparently induced by AEA binding and activating this transcriptional factor 
(Bouaboula et al., 2005; Karaliota, 2009), whereas the correlation between increase of the 
expression of PPARγ and the induction of the differentiation process was linear (Karaliota, 
2009). Again, the possibility that this effect could be indirect cannot be excluded, e.g. 
PPARγ expression and activation through anandamides metabolic FAAH or COX-2 
products (Karaliota, 2009) or by signaling pathways triggered by binding of AEA to CB1R 
or CB2R. 
 
2.3.3. Biochemistry of endocannabinoids 
 
In the classical “transacylation–phosphodiesterase pathway”, NAEs are formed from 
glycerophospholipids via N-acylphosphatidylethanolamine (NAPE) by sequential 
catalyses by Ca2+-dependent N-acyltransferase and NAPE-hydrolyzing phospholipase D 
(Schmid, 2000). Ca-NAT catalyzes the first reaction of this pathway, and transfers a fatty 
acyl chain from the sn-1 position of a glycerophospholipid molecule such as 
phosphatidylcholine (PC) to the nitrogen atom of the ethanolamine head group of PE to 
form NAPE. NAPE-PLD then hydrolyzes NAPE to NAE and PA. In addition to Ca-NAT, 
that has not yet been cloned, two other proteins, Ca2+-independent NAT (iNAT) and 
HRAS-like suppressor family 2 (HRASLS2), have been shown to be capable of forming 
NAPE by N-acylation of PE (Jin et al., 2007; Uyama et al., 2009; for review on NAE 
biosynthesis pathways, see Ueda et al., 2010). 
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The major degradative pathway of NAEs is enzymatic hydrolysis to correspondent fatty 
acid and ethanolamine by the catalysis of an enzyme referred to as fatty acid amide 
hydrolase (FAAH) (Deutsch and Chin, 1993; Ueda and Yamamoto, 2000; Ueda et al., 2000).  
Production and inactivation of different NAEs has been shown to occur independently of 
AEA and 2-AG production and inactivation. It appears that different ECs can be produced 
depending on the source responsible for the rise in intracellular calcium, specifically, 
released from intracellular stores or by influx through ionotropic receptors (Stella and 
Piomelli, 2001). These results strengthen the notion that multiple enzymatic pathways are 
involved in the production of each EC and that diverse stimuli control their independent 
production.  
One way that neurons and glial cells could increase distinct enzymatic pathways 
responsible for production of specific ECs is through the activation of different 
combinations of ionotropic and metabotropic receptors. For example, activation of 
nicotinic receptors increases AEA production, while activation of muscarinic receptors 
increases PEA production (Stella and Piomelli, 2001). Furthermore, Ueda and colleagues 
purified and characterized another fatty acid amidase, N-acylethanolamine-hydrolyzing 
acid amidase (NAAA) that has maximal activity occuring at pH 5 (compared to pH 7 of 
FAAH) and prefers PEA over AEA (having hydrolytic activities of 8 and 0.25 
nmol/min/mg, respectively) (Ueda et al., 2001).  
While within the same brain regions distinct ECs can be produced, their subcellular 
location also likely dictates their actions. Like many other bioactive lipophilic molecules, 
endocannabinoids partition into membranes, where they assume a thermodynamically 
favourable orientation and location. AEA alignment has been shown to be parallel to the 
lipid acyl chains: the ethanolamide group of AEA is located at the lipid-water interface 
and its acyl chain resides within the hydrophobic region of the bilayer (Lynch and Reggio, 
2005; Tian et al., 2005). Moreover, enzymes that are involved in anandamide biosynthesis 
and degradation are also membrane-bound, and their respective substrates and products 
originate from membrane phospholipids (Childers and Breivogel, 1998; for detailed 
review on AEA biosynthesis and degradation, see Placzek et al., 2008 or Wang and Ueda, 
2009). Data from various studies suggest that the integrity and composition of lipid rafts 
play a crucial role in endocannabinoid uptake and signalling through cannabinoid 
receptors (McFarland et al., 2004; Barnett-Norris et al., 2005). Rimmermann and collegues 
characterized the membrane compartmentalization of endocannabinoids and their lipid 
precursors, synthetic enzymes and receptors into caveolae, a lipid raft subtype rich in 
cholesterol, sphingomyelins, flotillin-1 and caveolin-1 (Rimmermann et al., 2008). 
The major pathway for the biosynthesis of 2-AG comprises sequential hydrolysis of 
arachidonic acid-containing inositol phospholipids by PLC and DAGL, the major enzyme 
to regulate 2-AG levels by hydrolysis to arachidonic acid and glycerol is monoacylglycerol 
lipase (MAGL; Dinh et al., 2002). The biochemical machinery for the production of 2-AG 
via DAG pathway is also localized within lipid rafts. Data by Maccarrone and coworkers 
(Maccarrone et al., 2009) indicate that disruption of raft integrity causes a complex 
alteration of the endocannabinoid signalling in the striatum. The observed co-localization 
of AEA, 2-AG, and their synthetic enzymes with the reported localization of CB1R raises 
the possibility of intrinsic-autocrine signalling within lipid raft domains and/or 
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retrograde-paracrine signalling. A detailed review on 2-AG biosynthesis and degradation 
was recently published by Wang and Ueda (2009). 
 
2.3.4. Mechanisms of cannabinoid receptor-mediated signaling  
 
At the subcellular level, most CB1Rs in mature animals are found on axon terminals. Since 
endocannabinoids are synthesized during periods of intense neuronal activity, the 
presynaptic localization of CB1Rs suggests that they might participate in a form of 
feedback inhibition, where the production of ECs in the post-synaptic cell inhibits release 
of transmitter (Schlicker and Kathmann 2001). Depending on the system, various 
transduction pathways downstream of CB1R have been described.  
Presynaptic inhibition of transmitter release by cannabinoid receptor activation is referred 
to as “endocannabinoid-mediated plasticity.” It is a mechanism that serves to either 
attenuate or enhance excitability, depending on the release of an excitatory or inhibitory 
neurotransmitter. It has been shown that cannabinoids are able to inhibit GABA 
(Wallmichrath and Szabo, 2002), glutamate (Shen et al., 1996), acetylcholine (Gifford et al., 
1997) and noradrenaline release (Schlicker et al., 1997). 
One form of endocannabinoid-mediated synaptic plasticity is depolarization-induced 
suppression of inhibition (DSI). DSI is a transient suppression of inhibitory 
neurotransmitter release onto a neuron following depolarization of that neuron (Llano et 
al., 1991; Pitler and Alger, 1994). In case of exitatory (glutamatergic) synapses, this 
phenomenon is referred to as depolarization induced suppression of excitation (DSE) 
(Kreitzer and Regehr, 2001). DSI and DSE appear to share the same properties and may be 
a general and important mechanism by which the postsynaptic neuronal activity can 
influence the amount of transmitter release.  
In case of cannabinoid signalling-induced DSI/DSE (sometimes referred to as “retrograde 
signaling“in literature), depolarization of the post-synaptic cell increases intracellular 
calcium, leading to a production of ECs from membrane phospholipids. These then diffuse 
across the synaptic cleft, activating presynaptic CB1 receptors. The way the newly 
synthesized ECs leave the postsynaptic plasma membrane to interact with presynaptically 
localized CB1R and the reuptake of ECs is still unclear, there are two possible mechanisms 
proposed: 1) simple diffusion; 2) passive (energy-independent) carrier proteins may be 
required to extrude ECs (Di Marzo et al., 1994; Piomelli et al., 1998). Besides this 
retrograde mode of signaling, some evidence suggests that ECs can trigger cellular 
responses (i.e., a decrease in neuronal excitability) within the cell that synthesizes them 
(Bacci et al. 2004). 
Endocannabinoids can also be synthesized following activation of post-synaptic Gq/11-
linked GPCR’s, most notably, group I metabotropic glutamate receptors and M1 and M3 
muscarinic receptors (Ohno-Shosaku et al., 2003, Varma et al., 2001). Most likely the 
endocannabinoid produced by this route is 2-AG. Similar to DSI and DSE, 
endocannabinoids synthesized by metabotropic receptor activation are thought to travel 
presynaptically to inhibit neurotransmitter release (Chevaleyre et al., 2006), although 
alternative processes involving nitric oxide have been suggested (Makara et al., 2007). 
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Figure 3. Schematic illustration of a model for synaptic endocannabinoid signaling. Synthesized 
in postsynaptic cell after calcium (Ca2+) influx, AEA and 2-AG restrain neural activity by 
binding to cannabinoid receptor 1 (CB1). Gi-protein-mediated signal cascade inhibits Ca2+ influx 
and cAMP production and elevates intracellular K+ to prevent additional neurotransmitter 
secretion by presynaptic neurons. AEA and 2-AG are taken up from the synaptic cleft into the 
post- and pre-synaptic neuron and hydrolyzed by FAAH or MAGL, respectively (Modified image 
from: Piomelli et al., 2007; Guzman, 2003; Piomelli, 2003) 
 
The activated CB1R decreases neurotransmitter release by inhibiting calcium channels and 
may also stimulate potassium channels or have direct effects on the synaptic vesicle 
release machinery (Wilson et al., 2001). CB1R activation leads to Gi/o-mediated inhibition 
of voltage gated L- (Gebremedhin et al., 1999), N - (Caulfield and Brown, 1992; Mackie 
and Hille, 1992; Pan et al., 1996, Pan et al., 1998; Guo and Ikeda, 2004) and P/Q-type 
(Mackie et al., 1995) calcium-channels and D-type potassium channels (Mu et al., 1999) 
(for reviews see Pertwee and Ross, 2002; Stelt and Di Marzo, 2005). The CB1R also 
activates at least two classes of potassium channels, the voltage-dependent potassium A 
current and inwardly rectifying potassium channels (GIRK or Kir3 channels) (Mackie et 
al., 1995; Jin et al., 1999). In contrast to CB1R, CB2R stimulation is believed not to modulate 
ion channel function (Felder et al., 1995; McAllister et al., 1999) but to alter the release of 
chemical messengers (e.g. cytokines from immune cells, reviewed in Walter and Stella, 
2004). 
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Following receptor activation, the Gi/o subunit inhibits adenylyl cyclase (AC) activity 
resulting in attenuation of intracellular cAMP production (Childers and Deadwyler, 1996) 
and subsequent inhibition of cAMP dependent PKA. In the absence of cannabinoids, PKA 
phosphorylates potassium channel (A-current), thereby exerting decreased outward 
potassium current. Inhibition of PKA by endocannabinoid signaling via cannabinoid 
receptor leads to an enhanced outward potassium current (Deadwyler et al., 1995; 
Hampson et al., 1995). CBR-mediated suppression of cAMP signalling through PKA has 
been proposed as the possible mechanism behind neuroprotective antioxidant effect of 
cannabinoids (Kim et al., 2005; Huang et al., 2002), synaptic plasticity and neuronal 
remodeling (e.g. Tyr-phosphorylation of focal adhesion kinase (pp125 FAK) pathway 
(Derkinderen et al., 1996; Derkinderen et al., 2001), neurite retraction in a neuroblastoma 
cell model (Zhou and Song, 2001) and inhibition of nerve growth factor (NGF)-induced 
neurite extension (Rueda et al., 2002)).  
Both CB1R and CB2R have been shown to stimulate p42/p44 mitogen-activated protein 
kinase (p42/p44 MAPK, also known as ERK) activity. CB1R-mediated ERK activation has 
been correlated to functions such as cell proliferation, transformation, and apoptosis 
(Bouaboula et al., 1995; Galve-Roperh et al., 2002); and has been shown to require 
activation of PKA (Davis et al., 2003), protein kinase C (PKC) and VGFRs (Rubovitch et al., 
2004) or EGFR (Hart et al., 2004). Mechanisms for ERK activation by CBRs appear to 
involve sequential recruitment of phosphatidylinositol-3-kinase (PI3K), tyrosine 
phosphorylation, and activation of Raf (MAPKKK) (Bouaboula et al., 1995; Bouaboula et 
al., 1996). Whereas all previous studies have been performed on non-neuronal cell 
cultures, a very recent study showed involvement of CB1R in biphasic ERK activation via 
multiprotein signaling complex formation of proximal kinases PKCε, Src, and Fyn in 
primary neurons (Asimaki and Mangoura, 2011). 
In contrast to the above studies, CBR-mediated stimulation of cyclic AMP production 
has also been observed in response to cannabinoid drugs (Maneuf and Brotchie, 1997; 
Bonhaus et al., 1998). This controversial effect of cannabinoid signaling on cAMP 
production could be explained by cellular production of an endogenous stimulator of AC. 
Cannabinoids are reported to stimulate AA release and prostaglandin synthesis (Burstein 
et al., 1986, Burstein et al., 1994), and prostaglandin synthesis, in turn, has been implicated 
in cannabinoid-mediated cyclic AMP production (Hillard and Bloom, 1983). Also, it is 
possible, that inhibition and stimulation of cAMP production could depend upon which 
isoform of AC is expressed in target cells and the way that the particular isoform responds 
to Gi/o-mediated regulation. Rhee and colleagues showed that activation of the 
cannabinoid receptors type 1 and 2 inhibited the activity of AC isoforms 1/3/5/6/8, whereas 
isoforms 2/4/7 were stimulated by cannabinoid receptor activation (Rhee et al., 1998). The 
third possible mechanism could be interaction between CB1R and Gs (Glass and Felder, 
1997; Felder et al., 1998; Bonhaus et al., 1998)  
Another signal transduction pathway regulated by cannabinoid receptors, especially of 
the CB2 type, is the synthesis of ceramide (rewieved in Velasco et al., 2005). CB1 receptor 
activation has been shown to induce sphingomyelin hydrolysis and acute ceramide 
production (Sánchez et al., 1998; Galve-Roperh et al., 2000). On the contrary, sustained 
ceramide accumulation through enhanced de novo synthesis seems to play a major role in 
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CB2R activation–induced apoptosis in tumor cells, including glioma (Galve-Roperh et al., 
2000, Carracedo et al., 2006a), leukemia (Herrera et al., 2006), and pancreatic cancer 
(Carracedo et al., 2006b). It has recently been shown that signaling through CBR increases 
ceramide production via a mechanism that involves TNF-α (Cianchi et al., 2008). 
 
2.3.5. C. elegans as a model to study ESC  
 
According to in silico experiments performed on genomes of different organisms to find 
orthologous genes to those of mammalian endocannabinoid system, nematodes did not 
appear to have much to offer. McPartland and coworkers (McPartland et al., 2006) looked 
at 10 genes known to encode proteins involved in endocannabinoid signalling. The 
capacity of orthologs to function as endocannabinoid proteins was predicted with pattern 
profilers (Pfam, Prosite, TMHMM, and pSORT), and by examining queried sequences for 
amino acid motifs known to serve critical roles in endocannabinoid protein function 
(obtained from a database of site-directed mutagenesis studies). Hereby, I will shortly 
review their results pertaining to C. elegans:  
CB1R and CB2R: C. elegans gene C02H7.2 was previously rejected as an ortholog because 
of its low similarity to HsCB1R (Elphick and Egertova, 2001) and because of it low FAS 
score (McPartland and Glass, 2001). Nevertheless, CeC02H7.2 claded with cannabinoid 
receptors, with good bootstrap support. McPartland and colleagues (McPartland et al., 
2006) suggest, that CeC02H7.2 may be an ortholog, but it might not function as a 
cannabinoid receptor, as its FAS score indicated substitutions at half the motifs required 
for mammalian CB1R to function.  
TRPV1: C. elegans ortholog for vanilloid receptor 1 (osm-9, Tobin et al., 2002) has, like the 
sequences of chicken and frog TRPV1 orthologs (Jordt and Julius, 2002), a substitution at 
T550 rendering the receptor capsaicin- and AEA-insensitive, as it is shown in chicken 
(Jordt and Julius, 2002). Whether or not this AEA insensitivity holds true for worm, is still 
to be determined.  
GPR55: HomoloGene identified no putative homologs of GPR55 in worm, whereas 
Unigene identified protein similarities between HsGPR55 and C. elegans 
allatostatin/galanin-like receptor npr-9 (ZK455.3).   
FAAH: Presence of a putative homolog of hsFAAH in C.elegans’genome (faah-1, 
B0218.1a), is consistent with our data of presence of its target, AEA, in worm (in III).   
NAPE-PLD: Both HomoloGene and Unigene identified a putative homolog of NAPE-PLD 
in C. elegans - Y37E11AR.4, again upholding the assertion of a functional AEA metabolism 
pathway in nematodes.  
MAGL: according to McPartland and collegues (2006), there are no homolog sequences of 
hsMAGL in C. elegans 
DAGLα and DAGLβ: 2-AG, the product of DAGLα and DAGLβ, has been extracted from 
C. elegans (in III). However, HomoloGene identified no DAGLα homologs in C. elegans. 
Unigene identified a single sequence in C. elegans, similar to both HsDAGLα and β: 
F42G9.6a gene. McPartland and coworkers interpreted the sequence as DAGL ortholog, 
with a duplication event that led to the eventual divergence of DAGLα and DAGLβ in 
vertebrates.   
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Recently, Lucanic and coworkers revealed the role of NAEs in C. elegans as signaling 
molecules in sensing nutrient availability and leading to metabolic changes that ultimately 
determine lifespan (Lucanic et al., 2011). In accordance with our findings (in III), they 
identified PEA, OEA and AEA in C. elegans, as well as palmitoleoyl ethanolamide (POEA, 
C16:1n7), linoleoyl ethanolamide (LOEA, C18:2n6) and eicosapentaenoyl ethanolamide 
(EPEA; 20:5n3). Consistently with mammalian studies (Leung et al., 2006), the production 
of NAEs via NAPE-PLD biosynthesis pathway seems to be regulated by a redundant 
mechanism in worms, since neither mutation nor RNAi of nape-1 reduced NAE levels 
(Lucanic et al., 2011). However, NAE levels can be reduced in worms by overexpressing 
faah-1, indicating a conserved function of faah-1 as a hydrolytic enzyme involved in NAE 
degradation (Lucanic at al., 2011). The notion that over expression of faah-1 leads to 
developmental delay coincides with the developmental profile of NAE levels peaking at 
the L2 stage and progressively declining into adulthood.  NAE levels are also low in 
starved animals (dietary restriction conditions) and will rise to normal levels after 
refeeding (Lucanic at al., 2011), again in accordance with rodent studies (Kirkham et al., 
2002; Izzo et al., 2010). Depending on the concentration of daumone ( the “dauer 
pheromone”) secreted by worms in case of overcrowding or starvation, the decision 
whether to proceed to reproductive growth or to enter the dauer stage is made at early L2 
stage (Jeong et al., 2005). After commitment to dauer formation NAE levels are reduced; in 
fact, exogenous treatment with one of the NAEs, EPEA, was shown to rescue the dauer 
phenotype of dauer constitutive mutants (Lucanic et al., 2011). These results indicate the 
role of NAE signaling in altering the metabolic status in response to nutrient availability. 
FAAH-1 over expression also resulted in increased lifespan (but only at normal food 
availability, not in case of dietary restriction) and resistance to thermal stress. However, 
lifespan extension resulting from faah-1 overexpression does not depend on DAF-16 FOXO 
transcription factor involved in dauer formation and longevity through insulin signaling 
pathway, but is rather regulated upstream of PHA-4/Foxa (Lucanic et al., 2011), a 
transcription factor specific to diet-restriction-induced longevity presumably by mediating 
levels of glucagon (Panowski et al., 2007).  
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3 Aims of the Study 
 
 
The importance of membrane lipids and lipid mediators in cellular processes has too often 
been overlooked. The composition of lipid pools is utterly important in energy 
homeostasis as well as cell signaling and neurotransmission. The nematode C. elegans, 
with a series of fatty acid metabolism mutants available is an amenable model for 
studying functions of lipid molecules. The agar plates the worms are cultivated on can be 
supplemented with different compounds including fatty acids and the response to dietary 
supplements can be analyzed by different behavioral assays, lipidomic (fatty acid 
profiling) or transcriptomic (microarray) approaches. Starting with the question, whether 
trans-fats, known to cause serious health complications in humans, may affect the viability 
of C. elegans, the results led us further to study PUFA metabolism and even further to 
PUFA derivates - endocannabinoid like molecules.   
The more specific aims of the study were:  
 
● To review the transcriptomic (microarray) approaches in C. elegans to see whether it 
would be a good model system for studying highly conserved biological process such as 
development, aging, and feeding 
   
● As their mechanism of action of trans-fatty acids is yet poorly studied at the molecular 
level, to test C. elegans as a possible model organsim for trans-fat studies by observing the 
response to dietary trans-oleic acid on worm viability and fertility 
 
● To find the possible mechanism how dietary trans-fat causes reduced life expectancy and 
progeny number of PUFA deficient fat-3 mutant by looking for gene expression 
differences by microarray analysis and differences in fatty acid profiles by GC-MS 
 
● To determine the presence of PUFA derivates AEA, 2-AG and other endocannabinoid 
like molecules in nematodes and to study the regulation of those molecules during 
starvation  
 
● To produce worm models for endocannabinoid research - transgenic C. elegans strains 
ectopically expressing human cannabinoid receptors in the nervous system  
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4 Materials and Methods 
 
 
Table 3 summarizes the methods used in the original publications in this thesis work.  
 
Table 3. Overview of methods used in this thesis.  
 
Method         Original publication 
 
Bioinformatics        II 
Microarray analysis       I, II     
Maintenance and storage of C. elegans     II, III, IV 
Preparation of cis- and trans-18:1n9 and 20:4n6 agar plates  II 
Life span/viability assay       II, IV 
Brood size/fertility assay       II, IV 
qRT-PCR         II 
Worm sample collection        II, III, IV 
Determination of overall fatty acid composition   II, IV 
Determination of endocannabinoids     III, IV 
Principle component analysis      IV 
Transgenic animal generation      IV 
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5 Results  
 
 
5.1. C. ELEGANS AS A MODEL TO STUDY CONSERVED BIOLOGICAL PROCESSES 
USING MIRCOARRAY ANALYSIS (I) 
 
Microarrays have been designed and utilized for C. elegans gene expression studies for 
over a decade now, providing gene expression profiles of C. elegans in different 
developmental stages and environmental conditions. In our review article (I), we describe 
the microarray studies that have used C. elegans and discuss the special considerations of 
nematodes as model organisms in this context. C. elegans gene expression profile has been 
studied to shed light to a range of topics.  
We reviewed four cross-species (e.g. humans, flies, worms, yeast etc.) compendium 
studies (Bergman et al., 2004; McCarroll et al., 2004; Stuart et al., 2003; Lefebvre et al., 2004) 
that were performed to reveal co-expression relationships and gene associations. Another 
compendium study (Kim et al., 2001) assembling data from five hundred microarray 
experiments has led to construction of 44 mountain topological map of co-expressed worm 
genes.  
To describe the possibilities to study transcriptional regulation of developmental 
processes using C. elegans microarray we reviewed seven articles (Hill etal., 2000; Jiang at 
al., 2001; Kniazeva et al., 2004; Portman et al., 2004; Reinke et al., 2000; Reinke et al., 2004; 
Wang and Kim; 2003) where gene expression profiles of different developmental stages, 
sexes or developmental mutants was compared. The five aging studies (Golden et al., 
2004; Lund et a., 2002; McElwee et al., 2003; McElwee et al., 2004; Murphy et al., 2003) 
reviewed were mostly concentrating on a developmental stage called “dauer larva” and 
the mutants in DAF-2/DAF-16 insulin-like signaling pathway that influences both dauer 
formation as well as life-span of adult worms. Five toxicological studies reviewed 
(GuhaThakurta et al., 2002; Huffmann et al., 2004; Kwon et al., 2004; Mallo et al., 2002; 
Nelson et al., 2002) reveal the effects of pathogenic bacteria, radiation, heat shock, ethanol 
etc. on C. elegans gene expression.  For cell biology studies however, C. elegans seems to be 
not a very suitable model organism, due to the difficulties to identify cell-specific 
transcripts. Two different approaches have been used to overcome this problem: FACS 
sorting of worms with labeled touch receptor cells (Zhang et al., 2002) and mRNA tagging 
(Roy et al., 2002).  From the several human disease models  produced by ectopic over-
expression of human disease genes (or worm orthologs of those) in C. elegans only a few 
gene-expression studies have been published (by the time our review was written), two of 
them were rewied (Link et al., 2003; Romagnolo et al., 2002) in our article. We also brought 
out the paucity of pharmacological studies among the worm microarray experiments, 
although the administration of exogenous compounds to worms is easy to accomplish.   
In several studies we reviewed in our article, micrroarray analysis has been combined 
with classical genetics.  The C. elegans mutant banks provide a reasonable amount of 
material for genetic studies. For example, there are over 3000 mutant strains available at 
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Table 4. Advantages (+) and disadvantages (-) of using C. elegans for microarray 
experiments. 
________________________________________________________________________________ 
+ Ability to obtain RNA from synchronized 
populations (based on developmental stage) 
 -  Complexity to perform single worm 
microarray experiments  
+ Minimal genetic heterogeinity  - Presence of polycistrons in the genome 
+ Appropriate genome size to fit onto one slide  - Incomplete gene annotation  
+ Availability of genetic mutants   
+ Availability of genetic, phenotypic and 
microarray information via WormBase  
 
+ Possibility to use in vitro cell culture  
+ Easy to compare microarray data due to limited 
number of microarray platforms 
 
 
 
Caenorhabditis Genetics Center. In case there are no appropriate mutants available, RNA 
interference could also be used to knock down the genes of interest with the intention to 
find downstream players. Also, RNAi could be used afterwards to assert the roles of the 
candidate genes emerged in the gene lists.  
To identify targets of transctription factors in some studies microarray analysis has been 
combined with bioinformatics approaches (McElwee et al., 2003; Murphy et al., 2003; 
Zhang et al., 2002). In these cases gene expression profiles of mutant or transgenic worms 
lacking or overexpressing a certain transcription factor gene, respectively, were compared 
to those of wild type and 5 flanking regions of differently expressed genes were compared 
to find conserved sequence motifs.   
A typical way to analyze the microarray data is to cluster the genes based on enriched 
gene ontology terms. This kind of “theme discovery“ or “data mining“ approach requires 
annotation of genes according to  biological prossess, molecular function and cellular 
localization. Data mining could also be extended to chromosomal localization, as was used 
in studies concerning sprem enriched genes (Reinke et al., 2000; Reinke et al., 2004).   
To summarize the topics considered in our review we analysed the advantages and 
disadvantages of utilizing C. elegans as a model organism for microarray experiments 
(Table 4). 
 We also provided tables with the information about available C. elegans microarray 
databases as well as C. elegans microarray manufacturers. However, as the review was 
written over six years ago, some of the sources may not be available by now. 
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5.2. DIETARY TRANS-FAT AFFECTS THE VIABILITY AND FERTILITY OF DELTA-6-
DESATURASE MUTANT, BUT NOT WILDTYPE N2 WORMS (II)  
 
5.2.1. Elaidic  acid supplementation leads to reduced survival rate of fat-3(wa22) 
mutants 
 
We performed lifespan analysis on wild type (N2, Bristol) worms as well as fat-3 (wa22) 
delta-6-desaturase mutant worms grown on NGM plates supplemented with 25 μM 
18:2n6 cis- or trans-triglycerides. Triglycerides were used since it more closely mimics the 
form taken in the human diet. Whereas in case N2 worms TG supplementation had no 
significant effect whatsoever on worms lifespan - lifespans in days ± SD were 19.8 ± 5.6 
(NGM), 19.8 ± 6.4 (cis), and 18.2 ± 5.4 (trans)(Figure 4A, Figure 4A in II), there was a clear 
difference in survival rates in the case of fat-3 mutants.  
The trans-TG fed fat-3 mutant animals had a significantly shorter average lifespan 
(Student’s t-test, p < 10−5) compared to controls: 20.1 ± 4.9 (NGM), 19.5 ± 5.3 (cis), and 14.5 ± 
6.7 (trans)(Figure 4B, Figure 4B in II). First deaths occurred already on the fourth day of 
trans-TG feeding and the death rate was high until day 13. However, the worms that had 
survived until then (21 worms of 50) had a lifespan similar to cis- and control worms (20.2 
± 4.5 (NGM), 20.5±4 (cis) and 20.7 ± 4.5 (trans)) (Figure 4C).  
 
5.2.2. Elaidic acid supplementation further reduces the brood size of fat-3(wa22) 
mutants 
 
To investigate the effect of TFA on fertility, we performed an assay where we counted the 
number of the progeny of TFA treated worms. As with lifespan assay, we used both N2 
and fat-3 (wa22) worms grown on NGM plates with 25 μM 18:2n6 cis- or trans-TG and 
compared the results with progeny number of worms grown on un-supplemented NGM 
plates. To determine if there may be a long-term effect, we observed the first and also the 
third generation of worms grown on TG-supplemented plates (Table 5; Figure 3 in II).  
 
 
Table 5.  Progeny size (average number of viable larvae) of N2 and fat-3(wa22) worms grown 
on control (NGM) plates, oleic acid- (18:1n9cis) and elaidic acid- (18:1n9trans) supplemented 
plates. F1 - first generation; F3 – third generation;,  and  correspond to p<0.05, p<0.01 
and p<0.001 respectively as compared to corresponding control (NGM). 
 
Strain Treatment F1  F3  
 NGM 274 ±27 278 ±28 
N2 cis 293 ±29 280 ±28 
  trans 274 ±23 274 ±31 
 NGM 182 ±26 168 ±31 
fat-3 cis 179 ±38   145 ±27   
 trans  144 ±39      90  ±53   
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Figure 4. Life span charts of C. elegans grown on control (NGM) plates, oleic acid- (18:1n9cis) 
and elaidic acid- (18:1n9trans) supplemented plates. A. Wild type (N2); B. fat-3(wa22) 
mutants; C. Life span chart of fat-3(wa22) when data of the worms that died before day 13 
was censored from the assay.  
 
 
In case of wild type N2 worms, no significant differences in progeny number were 
observed between worms grown on different triglycerides and also between different 
generations, suggesting again that TFA have no observable effect on worms with normal 
fat metabolism. Nevertheless, fat-3 mutant worms displayed a dramatic reduction in 
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brood size in response to trans-TG diet (144 ± 38, p < 0.003) when compared to the brood 
size of animals grown on cis-triglycerides plates (179 ± 38) or NGM controls (182 ± 26). 
This effect was even greater in third generation (p < 10−7), when the average number of 
viable progeny of worms grown on trans-TG plates was 90 ± 53 compared to 168 ± 30 of 
NGM controls. However, in third generation a significant reduction of progeny number 
took place also in cis-TG treated worms (145 ± 27, p < 0.016).  
 
5.2.3. Fatty acid profiles of worms grown on cis- and trans-isomer of oleic acid do not 
show any significant differences in case of either N2 or fat-3 worms  
 
We performed a fatty acid analysis of N2 and fat-3 (ok1126) deletion mutant worms grown 
on NGM plates supplemented with 25 μM 18:2n6 cis- or trans-triglycerides.  N2, fat-3 
(ok1126) and fat-3(wa22) worms grown on un-supplemented plates were used as controls. 
Changes in fatty acid composition were determined in whole worms at the L4 larval stage. 
As expected, both of the fat-3 mutants lacked all the PUFAs beyond C18:3n3. However we 
did not notice any significant changes in fatty acid composition between different 
conditions in either N2 or fat-3 (ok1126) strain (Figure 5 in II).   
 
5.2.4. Microarray data analysis using Gene Ontology (GO) suggests dietary trans fat 
affects PUFA-dependent developmental processes  
 
We performed a microarray experiment to determine the possible changes in 
transcriptional regulation in fat-3 (ok1126) mutants by dietary oleic acid isomers.  
We isolated and used RNA from synchronized L4 cultures of N2 grown on NGM plates, 
and fat-3 (ok1126) mutants grown on NGM, 25 μM 18:1n9cis-TG and 18:1n9trans-TG 
supplemented plates. Four independent biological replicates per worm treatment were 
hybridized individually onto C. elegans whole genome chips (Washington University, St. 
Louis, MO) that contained 22,490 oligo features.  
 
5.2.4.1. Gene expression differences between wild type (N2) and fat-3 mutants 
To observe the effects of the PUFA deficiency caused by fat-3 mutation, the expression 
profiles from the fat-3 (ok1126) deletion mutant and the respective N2 control were 
compared in a microarray experiment.  The gene lists of up- and down-regulated genes 
(656 and 487 genes, respectively; Figure 5A) achieved by using a criteria of twofold change 
and p<0.05 without multiple testing correction were analyzed to find significantly 
enriched biological process gene ontologies (GO). Using ontology enrichment analysis 
DAVID 6.7 Functional annotation chart we found a significant proportion of genes 
involved in developmental processes: postembryonic development (16%, 173 genes, p < 
10−6); embryonic development (23%, 242 genes, p < 10−7); and growth (12.3%, 131 genes, p < 
10−4). Also the analysis revealed structural constituent of cuticle among over represented 
GO terms (20 genes, p < 10-4). Gene list of differently regulated genes between N2 and fat-3, 
as well as gene lists from cis- and trans-fat treated fat-3 are available from author by 
request. 
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5.2.4.2. Gene expression differences between fat-3 mutants grown on cis-isomer and 
trans-isomer of oleic acid 
In comparison to fat-3 NGM control conditions, cis-TG supplementation resulted in the 
upregulation of 217 genes and downregulation of 119 genes (Figure 5B); and trans-TG 
feeding in 288 up regulated and 80 downregulated genes (Figure 5C). There were 63 
overlapping genes in these gene lists, 24 of which were common to those regulated 
between fat-3 and N2. There were 21 genes in common in gene lists from cis- vs. trans-fat 
treatment comparison (gene list D in Figure 5a) and both fat treated vs. control fat-3 
comparisons (gene lists B and C in Figure 5a)(Table 6).  
 Lists of cis- and trans-fat regulated genes (vs. NGM control) and differently regulated 
genes between cis- and trans-TG treatments are provided in Supplementary Data (Table 1 
and Table 2, respectively).  
Gene ontology terms enriched in fat-3 mutants following cis-TG feeding were similar to 
those of non-treated fat-3 animals involved in developmental processes like growth (16%, 
53 genes, p < 10−6), post-embryonic development (19%, 63 genes, p < 10−6), and larval 
development (19%, 62 genes, p < 10−6). The same gene ontology terms were enriched as 
well in case of trans-TG feeding: growth (17%, 61 genes, p < 10−7), larval development 
(21%, 75 genes, p < 10−8), and cuticle development (2.3%, 8 genes, p < 10−3); however, over 
representation of genes involved in translation (8%, 29 genes, p < 10−11), ribosome 
biogenesis (2.3%, 8 genes, p < 10−4) and cuticle development (2.3%; 8 genes, p =0.005) was 
also noted (TABLE 1 in II).    
 
5.2.4.3. Quantitative real-time PCR performed on fat metabolism genes from microarray 
gene lists 
We preformed qRT-PCR on several genes known to be involved in fat metabolism that we 
found to be regulated from the microarray experiment (TABLE 2 in II). cis- and trans-TG 
treatment of fat-3 worms led to dramatic induction of acs-2, a gene highly responsive to 
nutrient state, as well as modest yet significant changes (p<0.05) in other responsive genes 
fat-7, daf-16 and mdt-15 (only in case of trans-TG feeding). Modest induction was also seen 
in mai-2 (a C. elegans homologue of endogenous mitochondrial ATP hydrolase inhibitor 
IF(1)) and let-767 (steroid dehydrogenase required for LC-PUFA and mmBCFA 
production) (p<0.01) and C-type lectin domain (CTLD) containing protein clec-85 (p<0.05).  
Highly significant decrease of gene expression (p<0.001) was observed in all conditions (in 
fat-3 compared to N2 as well as both cis-TG and trans-TG treated vs. untreated fat-3) for 
egg-1.  
 
 
  
43
 
 
 
Figure 5. Schematic representation of A. the number of up-() and down-() regulated genes 
in four gene lists achieved by microarray analysis;  B. the number of overlapping genes 
regulated by cis or trans fat treatment, compared to the strain effect in NGM treatments. Gene 
lists: A) wild type (N2) versus fat-3(ok1126) worms grown on control (NGM) plates; B) fat-3 
control vs. the cis fat treated worms; C)  fat-3 control vs. the trans fat treated worms; D) cis 
fat treated vs. trans fat treated fat-3 worms. 
 
 
Table 6. The genes with a significant difference between cis and trans fat treatments (gene list 
D in Figure 5a) which also had a significant difference between the expression in a fat treated 
and control (NGM) fat-3 set (gene lists B and C in Figure 5a).  
 corresponds to p<0.05 as compared to corresponding control (NGM). 
 
 
Sequence name 
 
Public name N2 NGM fat-3 NGM fat-3 cis fat-3 trans 
Y54G2A.14 clec-83 7.23 ± 5.97 5.20 ± 2.61 14.92* ± 4.10 6.91 ± 3.58 
K11G12.5  9.32 ± 5.57 4.89 ± 3.70 15.78* ± 7.15 6.71 ± 2.29 
D2023.2 pyc-1 3.59 ± 2.53 5.12 ± 2.69 11.75* ± 5.02 5.56 ± 2.11 
F09E5.11  1.41 ± 1.30 1.65 ± 1.13 0.38* ± 0.21 1.24 ± 1.00 
K04C2.2  2.60 ± 1.97 3.15 ± 2.98 0.55* ± 0.56 2.91 ± 3.34 
F21F8.3 asp-5 14.58 ± 2.19 8.75 ± 2.66 12.46 ± 5.56 57.00* ± 29.95
F10B5.1 rpl-10 24.81 ± 9.23 9.02 ± 3.08 6.93 ± 2.34 28.77* ± 14.83
Y105C5B.21 jac-1 0.55 ± 0.07 0.31 ± 0.09 0.30 ± 0.08 0.70* ± 0.20 
K12B6.2  0.50 nd 0.28 ± 0.06 0.25 ± 0.09 0.63* ± 0.05 
F53G12.3 duox-2 1.38 ± 1.64 0.39 ± 0.27 0.43 ± 0.22 1.67* ± 1.30 
Y56A3A.12a faah-4 0.93 ± 0.38 0.26 ± 0.03 0.35 ± 0.13 0.74* ± 0.11 
Y48C3A.5a  0.59 ± 0.25 0.39 ± 0.07 0.39 ± 0.13 1.01* ± 0.44 
F55G1.12  0.47 ± 0.19 0.47 ± 0.05 0.45 ± 0.08 1.00* ± 0.00 
ZK353.5  0.68 ± 0.08 0.49 ± 0.17 0.39 ± 0.12 1.23* ± 0.32 
F36G9.14 fbxa-99 nd nd 0.30 ± 0.03 0.29 ± 0.04 0.70* ± 0.04 
T16A9.2 str-230 0.67 nd 0.27 ± 0.06 0.24 ± 0.01 0.65* ± 0.02 
Y48E1C.3 tbc-15 0.84 ± 0.67 0.32 ± 0.09 0.30 ± 0.08 0.70* ± 0.04 
B0035.16  0.80 ± nd 0.31 ± 0.15 0.24 ± 0.01 0.65* ± 0.02 
C05D10.4c  2.20 ± 2.26 0.36 ± 0.21 0.35 ± 0.13 0.79* ± 0.17 
T28A11.18  0.94 ± 0.41 0.36 ± 0.19 0.35 ± 0.13 0.74* ± 0.11 
F12B6.2b  nd nd 0.31 ± 0.12 0.24 ± 0.01 0.73* ± 0.09 
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5.3. IDENTIFICATION OF ENDOCANNABINOIDS IN THREE NEMATODE SPECIES 
(III) 
 
We identified AEA and 2-AG as endogenous products from nematodes C. elegans, C. 
briggsae and Pelodera strongyloides by using electrospray ionization ion trap MS/MS (ESI-
ITMS) experiments operated in the positive ionization mode. We identified AEA and 2-
AG in the C. elegans natural isolates N2 (reference strain, isolated from soil in Bristol, UK), 
AB1 (Australia), CB4856 (Hawaii) and TR403 (Madison, WI) strains. AEA and 2-AG were 
identified by product ion scan and concentrations were measured by triple quadrupole 
mass spectrometry in the multiple reaction monitoring mode (MRM). 2-AG was 
approximately 50-fold more abundant than AEA. In C. elegans delta-6-desaturase mutant 
fat-3 (ok1126) which lacks arachidonic acid, the precursor for AEA and 2-AG, no detectable 
amounts of those molecules were found. Other acylethanolamides like oleoyl 
ethanolamide (OEA) and palmitoyl ethanolamide (PEA) were identified in all three 
nematode species, all three C. elegans natural isolates and fat-3 strain (data not shown). In a 
later study (publication IV) we also identified linoleoyl-ethanolamide (LEA; C18:2n6) in C. 
elegans.    
 
5.4. PAN-NEURONAL EXPRESSION OF HUMAN CANNABINOID RECEPTORS IN 
C. ELEGANS PRODUCES AN OBSERVABLE PHENOTYPE (IV) 
 
We generated transgenic C. elegans strains expressing human CBR1 and CBR2 in all 
neurons (CBR coding regions driven by pan-neuronal promoter paex:3). GFP was used as 
a fluorescent marker expressed in dopaminergic neurons (driven by dopamine transporter 
promoter pdat-1). The CBR1 line has the transgene as extrachromosomal array; therefore 
we used only more stable CBR2 integrated lines for brood size and lifespan analysis. We 
measured the reproductive success in two CBR2 lines (from chromosomal transgene array 
integration using x-ray irradiation) compared to wildtype N2 worms. While average 
progeny number of 30 N2 animals was 280 ± 30, the average brood sizes of trangenic CBR2 
were significantly lower: 200 ± 36 (CBR2 line 6-3) and 199 ± 30 (CBR2 line 7-8) (Table 7; 
Figure 4A in IV) (p<0.001, t-test).    
Lifespan assay revealed significant differences (p<0.001, t-test) in average life expectancy 
of transgenic CBR worms compared to 19.9 ± 4.6 days of N2 controls: 15.4 ± 4.8 for CB2R 
line 1 (Is6-3) and 16.9 ± 4.6 for CB2R line 2 (Is7-8) (n=30 animals ± STD) (Figure 6; Figure 4 
B in IV) 
 
 
Table 7. Progeny size (average number of viable larvae) of wild type (N2) and two independent 
lines (Is6-3 and Is7-8) of transgenic worms with pan-neuronal expression of human 
cannabinoid receptor 2 (aex-3::CB2R; dat-1::GFP). corresponds to p<0.001 as compared 
to N2 strain. 
 
Strain        № of larvae 
N2 280 ±30 
line 1 (Is6-3) 200 ±36  
line 2 (Is7-8) 199 ±30  
  
45
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 5 10 15 20 25 30 35
Days
F
ra
c
ti
o
n
 a
li
v
e
N2 
line 1 (Is6-3)
line 2 (Is7-8)
 
 
Figure 6. Life span chart of two independent lines (Is6-3 and Is7-8) of transgenic worms with 
pan-neuronal expression of human cannabinoid receptor 2 (aex-3::CB2R; dat-1::GFP) 
compared to wild type (N2).  
 
 
5.5. STARVATION CHANGES FATTY ACID PROFILES AND ENDOCANNABINOID 
LEVELS DIFFERENTLY IN WILDTYPE N2 AND TRANSGENIC WORMS 
EXPRESSING HUMAN CANNABINOID RECEPTORS (IV) 
 
5.5.1. Starvation lead to changes in fatty acid profiles in both N2 and CBR transgenic 
worms 
 
Nematodes lack functional homologues for human cannabinoid receptors (McPartland et 
al., 2006). We generated transgenic C. elegans strains expressing human CBR1 and CBR2 in 
all neurons (CBR coding regions driven by pan-neuronal promoter paex-3). GFP was used 
as a fluorescent marker expressed in dopaminergic neurons (driven by dopamine 
transporter promoter pdat-1) (Lakso et al., 2003). 
Fatty acid analysis of starved N2 worms revealed significant changes compared to fed 
worms in six out of about 20 FAMEs analyzed. Levels of omega-3 LC-HUFAs ETA 
(20:4n3) and EPA (20:5n3), as well as mmBCFA 15:isoB were significantly increased 
(Figure 7G,I and B, respectively), while PA (16:0) and SA (18:0) and vaccenic acid (18:1n7) 
levels were decreased in starved worms (Figure 7C,D and E) (p<0.001, one-way ANOVA, 
Newman-Keuls post-hoc test). Omega-6 fatty acids LA (18:1n6) and AA (20:4n6), however, 
showed no change (Figure 7F, H).  
In contrast, in transgenic CB1R and CB2RR animals the stearic acid (C18:0) levels did not 
change (Figure 7D) and the mmBCFA 15:isoA and 15:isoB levels decreased (p< 0.001, one-
way ANOVA, New-Keuls post-hoc test) in response to starvation (Figure 7A and B). 
Interestingly, LA and AA levels were increased in starved CB2R (p<0.001 and p<0.05, 
respectively), but not CB1R transgenic animals (Figure 7F). Levels of C16:0, C18:1n7, 
C20:4n3 and C20:5n3 were similar between wild type and transgenic CB1R and CB2R 
animals (Figure 7C, E, G and I). 
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Figure 7. Percentages of fatty acid methyl esters in fed (filled bars) and starved (empty bars) 
animals. Bars are means of measured fatty acid methyl esters from of three independent 
biological samples ± standard deviation. ,  and   correspond to p<0.05, p<0.01 and 
p<0.001 respectively comparing fed and starved for each worm strain. Only fatty acids methyl 
esters having at least 5% in fed or starved N2 animals are shown 
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Figure 8. Amounts of endocannabinoids in fed (filled bars) and starved (empty bars) animals. 
Bars are means in pmol/mg of three independent samples ± standard deviation. ,  and   
correspond to p<0.05, p<0.01 and p<0.001 respectively comparing fed and starved for each 
worm strain. Values of 2-AG and AEA are obtained from the summation of n3 and n6 forms 
(AA and EPA derivatives, respectively). 
 
5.5.2. Ectopically expressed human cannabinoid receptors attenuate starvation induced 
decrease of worm endocannabinoid levels 
 
Starvation led to significant decrease in N-acylethanolamine (AEA, PEA, OEA and LEA) 
levels in N2 animals (Figure 8C, D, E, F). However, most of the decrease in overall EC 
levels was attributable to 2-AG (Figure 8A). In CBR transgenic animals, this response to 
starvation was attenuated (Figure 8A), again mostly for 2-AG (Figure 1B), but in CB2R 
transgenic animals also for all NAEs (Figure 8C, D, E, F). In CB1R transgenic animals this 
effect on NAE levels was seen only in OEA (Figure 8E). 
AEA and 2-AG levels shown in Figure 8 were combined from AEAn3 + AEAn6 and 2-
AGn3 + 2-AGn6, respectively, whereas the n3 and n6 peaks were considered separately in 
principal component analysis (Figure 3 in IV).  PCA was performed on sample data from 
wild type and transgenic worms in both fed and starved conditions. The first component 
(PC1, 49% of the variation) separated the samples to clear clusters by condition (starved 
and fed), while the second (PC2, 15% of the variation) separated the wild type from 
transgenic worms (Figure 3A in IV). According to PC1, ECs showed positive correlation 
with fed state, whereas several FAMES including omega-3 PUFAs were associated with 
starvation (Figure 3B in IV). Omega-6 PUFAs, however, did not show a strong correlation 
to starved state.  
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6 Discussion  
 
I 
 
A hermaphrodite C. elegans is a tiny animal (ca 1 mm in length) that has a simple body 
plan with only 959 somatic cells. Despite the small number of cells it has a variety of 
organs and tissues like muscle, hypodermis (skin), intestine, reproductive system and 
glands. Its nervous system, containing only 302 neurons, is characterized to the level of 
synaptic connections. More than a decade ago, the C. elegans genome was sequenced (The 
C. elegans Sequencing Consortium, 1998). Though the number of basepairs is about thirty 
times smaller than that of humans (only 97 million bp), the worm genome is rather dense 
with genes, coding for more than 20,000 different proteins plus containing about 16 000 
non-coding RNA genes (Ruby et al, 2006). Also, worms and humans share a number of 
conserved disease pathways, in fact C. elegans homologues have been identified for 60–
80% of human genes (reviewed in Kaletta and Hengartner, 2006). Of course the 
pharmacological effects seen in C. elegans model cannot be directly compared to humans 
(as even in case of mammalian models), but they can be used in early research to deliver 
fast answers on a molecular basis (e.g. the molecular function of a gene). 
All this makes C. elegans an ideal model organism, on one hand it is easy to cultivate and 
maintain, with a transparent tiny body simple to observe under the microscope; on the 
other hand the worms’ cellular and metabolic complexity is sufficient to be compatible 
with most of the mammalian systems. Of the animal models, C. elegans is certainly the 
fastest and most amenable to cost-effective medium/high-throughput technologies. 
Besides all the advantages of the worm model in microarray experiments, there are only a 
few minuses. At least one of them - incomplete gene annotation - is probably conquerable 
in near future as the amount of information about C. elegans gene function is steadily 
increasing. Next to transcriptome data, high-throughput shotgun proteomics experiments 
provide information to improve genome annotation by confirming a large number of 
predicted genes experimentally, eliminating errors in gene models, and identifying novel 
genes (Merrihew et al., 2008). According to WormBase Gene Ontology Progress Report 
released in March 2010, information about  biological prossess, molecular function and/or 
cellular localization is available for over 16,000 worm genes.  
Our review article on C. elegans microarray published on 2005 is most probably outdated 
by now. The SPELL microarray resource (Hibbs et al., 2007) on Wormbase database 
(www.wormbase.org) provides a list of 115 C. elegans microarray publications since the 
beginning of this century, 72 of them were published during the 2006-2010, half of those 
during the last two years of this period. These numbers indicate the continuous rise in 
utilization of C. elegans in high-throughput gene expression studies.  
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II 
 
Lipid research is using C. elegans as a model organism has advanced rapidly in the last two 
decades. Nematodes possess homologues of all the enzymes required for fatty acid 
metabolism in mammals, plus some extras. In fact, they have no dietary requirements for 
essential fatty acids as they can convert oleic acid to linoleic, as well as omega-6 fatty acids 
to their omega-3 counterparts (Wallis et al., 2002). Several mutants of desaturases, 
elongases etc. are available to study FA metabolism (Watts and Browse, 2002). As a 
cholesterol auxotroph, C. elegans is an amenable model for studying sterol metabolism and 
function (Matyash et al., 2001; Wüstner et al., 2010). Further manipulation of nematode 
fatty acid pool can be achieved by dietary supplementation with fatty acids (Watts et al., 
2003).  
Ingestion of trans fats, produced mainly by food industry using partial hydrogenation of 
liquid oils, is considered one of the major causes of health problems in modern world (e.g. 
elevating the risk of coronary heart disease, diabetes, cancer and infertility). The elaidic 
acid (EA, 18:1n9t), the trans isomer of the mono-unsaturated oleic acid (18:1n9c), is the 
prevailing isomer present in partially hydrogenated fats. As the precise mechanism of 
how trans isomerism of fatty acids may disrupt the cellular homeostasis is not yet known, 
we decided to use NGM agar plates supplemented with 25 μM either elaidic or oleic acid 
triglycerides to study the effect of trans fats on C. elegans on organismal (lifespan and 
brood size assays) and transcriptional (microarray study) level.  
The reduced survival rates and progeny number observed in fat-3 (wa22) mutants grown 
on trans-TG supplemented plates led us to hypothesize that trans-fat toxicity may be 
caused by accumulation of EA in cells, disrupting the normal lipid homeostasis and 
leading to defects in fertility and egg-laying. As animal and cell culture studies have 
shown that high intakes of trans fats inhibit the formation of long-chain polyunsaturated 
fatty acids (De Schrijver and Privett, 1982; Larque et al., 2003) we hypothesized that this 
may also be the case in C. elegans fat-3 mutants.  
The fact that trans fat diet did not change the fatty acid profiles of either wild type or 
PUFA deficient mutants may suggest that adverse effects of trans-TG on PUFA deficient 
mutants are likely not caused by accumulation of trans fats but may rather be related to 
more subtle effects, such as alterations in localized pools of fatty acids or changes in fatty 
acid signaling molecules. Studies performed on mammals show that trans fatty acids in the 
diet are incorporated into brain cell membranes, including the myelin sheath that insulates 
neurons (Grandgirard et al., 1994). The trans fats replace the cis fats in the membrane, and 
this appears to affect the electrical activity of the nerve cell. Specific expression of wild-
type copies of fat-3 in only the nervous system rescued the egg-laying and locomotion 
defects of fat-3 mutants (Marza and Lesa, 2006) suggesting that PUFA production in 
neurons only may be sufficient to regulate those behaviors. It cannot be ruled out that 
trans-TG supplementation may cause minor changes in fatty acid composition in neuronal 
cells that are not detectable by fatty acid profiling of whole animals, but sufficient to 
disrupt normal neuronal function and exacerbate egg-laying defects of PUFA deficient 
worms.  
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It appears that the decrease in lifespan was not due to changes longevity regulation but 
rather due to the toxic effect of trans-fats on PUFA deficient animals. Those worms were 
notably less viable and became smaller and flaccid compared to the control and cis-
triglyceride fed worms. Most of the dead worms had either a burst vulva or bagging (eggs 
hatching inside the mother eventually killing the animal) phenotype, suggesting 
complications in egg-laying/vulva muscle function.   
Next to the lifespan study described in Results we also performed a similar assay using 
fluorodeoxyuridine (FUdR), a compound routinely used in C. elegans lifespan assays to 
prevent egg laying and thus avoid the need to transfer the worms to new plates during the 
reproductive stage - FUdR incorporates into RNA and thereby ceases the development of 
the eggs. To our surprise there were no observable differences in lifespan on trans-TG fed 
and control worms in this case (data not shown). This effect of FUdR on trans-fat toxicity 
may also suggest that trans-fats affect the worms vulval muscle function: lack of progeny 
production by itself eliminates the deadly phenotypes of burst vulva and bagging. 
Interestingly, a recent short communication by Aitlhadj and Stürzenbaum shows that 
FUdR treatment can lead to increased longevity in another fat metabolism mutant 
(Aitlhadj and Stürzenbaum, 2011). TUB-1, a homolog of the mammalian tubby family, is 
involved with the modulation of fat storage (Ashrafi et al., 2003). The PUFA deficiency 
caused by lack of delta-6-desaturase activity in fat-3 mutants by itself displays pleiotropic 
abnormalities (e.g. cuticle defects, decreased defecation and feeding rates and decreased 
mobility (Watts et al., 2003)). Three of four muscle groups of C. elegans -pharyngeal, body 
wall and enteric muscles - have been shown to require fat-3 function in neurotransmitter 
release at cholinergic and serotonergic neuromuscular junctions (NMJs). Vulval and 
uterine muscles, however, are probably not affected by lack of PUFA (Watts et al., 2003). 
Based on our data, it is tempting to speculate that TFA may exacerbate the defects 
characteristic to PUFA deficiency by disturbing the neurotransmission controlling vulval 
and uterine muscles.   
PUFA deficient fat-3 worms have already a reduced brood size by about one third (i.e. 150 
to 200 worms compared to ca 300 of N2) in normal conditions and fat-3 mutants lay eggs at 
approximately half the rate of wild type (Watts et al., 2003). However, this cannot be 
attributed to PUFA deficiency induced defects in neurotransmission in vulval and uterine 
muscles, as the newly laid eggs are in the same developmental stage as those laid by wild 
type (Watts et al., 2003). One possible explanation for reduced fertility in fat-3 worms may 
lay in requirement of PUFA function in oocytes to control directional sperm motility 
within the uterus (Kubagawa et al., 2006). fat-3 (wa22) hermaphrodites have reduced 
fertilized egg production compared with wild type (Watts et al., 2003), due in part to 
sperm loss from the reproductive tract. The fat-2 mutants, which lack delta-12-desaturase 
responsible for converting OA to LA, have even more severe sperm motility defects than 
fat-3 mutants; yet fat-1 (lacking omega-3 PUFAS) and fat-4 mutants (which fail to produce 
AA and EPA) display no defects in sperm motility (Kubagawa et al., 2006). These results 
are suggesting that it is C18 rather than C20 PUFAS that are precursors of signals that 
control directional sperm motility. 
 Smaller than wild type brood size of fat-3 worms and further reduction of progeny 
number during generations on fat-diet might be correlated with decreased egg-1 
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expression. EGG-1 is a LDL receptor-type protein proposed to be involved in sperm 
guidance, but its particular role is not yet understood (Kadandale et al., 2005). Whether or 
not trans-fat diet is somehow disrupting PUFA mediated oocyte to sperm communication 
is yet to be confirmed. One might speculate that the trans isomer of oleic acid might 
somehow inhibit the delta-12-desaturase (fat-2) activity resulting in loss of C18 PUFA 
signal from oocytes and reduced sperm motility. The reason why we used fat-3 but not fat-
2 mutant worms in this study is that, besides small brood size and poor viability of fat-2 
mutants in itself, already in first generation only 7% of eggs laid by trans-fat fed fat-2 
hermaphrodites hatched (data not shown) and further studies would have been pointless.  
The large number of regulated genes from the development ontology class suggests that 
PUFAs may regulate developmental processes at the transcriptional level. In accordance 
with defects in cuticle composition observed in fat-3 mutants (Watts et al., 2003), our 
microarray data showed over/representation of cuticle genes.  As lipids in form of free 
fatty acids, triglycerides, cholesterol esters, PI, and PC are among key components of 
cuticle, it would be reasonable to predict that disrupted fatty acid biosynthesis could affect 
cuticle integrity and prevent normal cuticle formation. Recently it has been demonstrated 
that down regulation of the proteins encoded by fatty acid biosynthesis genes fasn-1 and 
pod-2 also causes impairment of the molting process and cuticle formation in C. elegans (Li 
and Paik, 2010). Nandakumar and Tan (2008), propose a link between polyunsaturated 
fatty acids and regulation of basal immunity in C. elegans. Their qRT-PCR experiments on 
50 infection-response genes, in order to observe differences in gene expression between 
fat-3 (wa22) and N2 worms, found 12 genes with decreased and 10 genes with increased 
basal expression in the fat-3(wa22) mutant relative to wild type. Comparing these results 
with our microarray data, we found four genes that were similarly regulated: thn-2 
expression was higher, while ZK6.11, F35E12.7 and F35E12.8 were lower in fat-3 mutants 
according to both our microarray gene lists and their qRT-PCR results.  
The results showed that fat-3 mutant animals respond strongly at the gene expression level 
to fat feeding and confirm that animals have ingested the added triglycerides. The 
decrease in brood size in third generation of fat-3 mutants grown on cis-TG supplemented 
plates is leading to an assumption that excess fat in any form may have an adverse effect 
on fertility of PUFA deficient animals.  
 
 
III 
 
The endocannabinoids arachidonoyl ethanolamide (AEA, anandamide) and 2-
arachidonoylgluycerol (2-AG) are known as ligands for endocannabinoid receptors CBR1 
and CBR2 and are found in peripheral and central nervous systems of most eukaryotic 
organisms including various species of invertebrates. Insects, however, seem to lack both 
CBRs and their ligands (McPartland et al., 2001) and ecdysozoa (e.g. centipedes) are 
shown to produce 2-AG but do not express CB receptors (Fezza et al., 2003; McPartland et 
al., 2001; De Petrocellis et al., 2000). The CBR1-like sequences that have been found in 
nematodes have low similarity to mammalian CBR1 and functional mapping suggests that 
these sequences do not result in functional cannabinoid receptors (McPartland et al., 2006). 
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However, C. elegans genome contains homologs of genes for both EC biosynthesis (nape-1 
for NAPE-PLD) and degradation (faah-1 for FAAH). We determined that unlike insects, C. 
elegans produces considerable amounts of the AEA and 2-AG precursor arachidonic acid 
(AA). Besides those, it also produces N-acylethanolamides (NAEs) oleoyl- (OEA) and 
palmitoyl-ethanolamide (PEA) (unpublished results) that have been found to exhibit 
cannabimimetic properties. Lucanic and coworkers (Lucanic et al., 2011) have also recently 
shown presence of several NAEs (besides aforementioned also palmitoleyl-, linoleyl- and 
eicosapentaenayl-ethanolamide (POEA, LOEA and EPEA, respectively) in C. elegans.   
Besides C. elegans reference strain N2, we identified AEA and 2-AG in lipid extracts of 
several natural isolates as well as other nematode species like Caenorhabditis briggsae and 
Pelodera strongyloides. P. strongyloides is a facultative parasite of mammals that belongs to 
Pleiorhabditis clade of nematodes and is so far much less studied than the Caenorhabditis 
species. C. briggsae is closely related to C. elegans, exerting only subtle morphological 
differences. The whole genome sequencing and assembly projects have revealed that 62% 
of the protein coding genes in C. briggsae have orthologs in C. elegans. According to 
WormBase database, C. briggsae as well as some other species from the same genus (C. 
remanei, C. japonica and C. brenneri) and a diplogastrid nematode Pristonchus pacificus do 
possess orthologs for both C. elegans faah-1 and nape-1 genes, leading to an assumption that 
endocannabinoid signalling is spread over the whole phylum. What are the targets of 
these molecules in nematodes is not yet known. It has been shown in several 
pharmacological and biochemical studies with mammalian models  that AEA can, at least 
in vitro, additionally activate non-CBR1 non-CBR2 receptors including vanilloid receptor 
TRPV1 and peroxisome proliferator-activated receptors (PPARs) (DiMarzo et al., 2002: 
DiMarzo et al., 2000), both of which have homologs in C. elegans.  In C. elegans, GPCR gene 
family comprises the most members (ca 1100 i.e. about 5% of the genome) and only a 
handful of these have been deorphanized so far. It can not be ruled out that there might be 
additional GPCR type cannabinoid receptors in nematodes that are absent or not yet 
discovered in mammals.  
 
 
IV 
 
As the derivatives of membrane-bound polyunsaturated fatty acids, endocannabinoids 
AEA and 2-AG, their levels are dependant on dietary PUFA intake (Berger et al., 2001; 
Watanabe et al., 2003; Matias et al., 2008). Recently, Lafourcade and coworkers showed 
that endocannabinoid-mediated synaptic depression is abolished by life-long PUFA 
deficiency (Lafourcade et al., 2011). Based on these results it is tempting to infer that 
dysfunction of endocannabinoid system may be at the bottom of the plethora of health 
problems bound to imbalance of dietary fat intake in Western diet. The identification of 
endocannabinoids in nematodes (III) which have supposedly no functional cannabinoid 
receptor homologues (McPartland et al., 2006) raised the question whether this animal 
model could be used to study the interplay between diet and ECS. Endocannabinoid levels 
have been shown to change during food deprivation in both mammals (Hanus et al., 2003; 
Petersen et al., 2006; Izzo et al., 2010) and C. elegans (Lucanic et al., 2011). We generated 
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worm strains with pan-neuronal expression of human cannabinoid receptors CB1R and 
CB2R, and showed that the starvation induced reduction of EC levels is attenuated in 
these strains. Furthermore, although starvation changes the fatty acid profiles of both wild 
type N2 and CBR transgenic worms, these changes are somehow different, particularly in 
case of monomethyl branched chain fatty acids C15isoA and B. Dietary BCFAs have 
attracted much attention in recent years, due to their strong link cancer as well as their role 
in neurological disease. C15ISO has been shown to be a growth inhibitor in human cancer 
by inducing apoptosis (Yang et al., 2000). In contrast to mammals, C. elegans is able to de 
novo synthesize C15iso and C17iso mmBCFAs and these are incorporated into sphingoid 
bases of glycosylceramides and sphingomyelin (Chitwood et al., 1995). What is the role of 
mmBCFAs in starvation response and whether the decrease of C15iso levels in starving 
transgenic CBR worms has to do with cannabinoid signaling-induced apoptosis (e.g. via 
ceramide production) (Herrera et al., 2006) is yet to be determined. The differences in fatty 
acid profiles and particularly EC levels between CB1R and CB2R transgenic lines might, 
however, require additional checkup, since the experiments were performed on using a 
CB1R strain carrying the transgene as an extrachromosomal array. In large population of 
such strains, the proportion of animals that have lost the array might rise to a level where 
it could affect the credibility of the results.  
It is noteworthy that with LC-MS method MRM channels of 2-AG and AEA show two 
peaks, one from AA and another from EPA attached to the glycerol and ethanolamide (in 
IV; Lehtonen et al., 2011). Omega 3 endocannabinoids EPEA and 2-EPG are scarcely 
studied, however recent studies show that EPEA as well as docosahexaenyl ethanolamide 
(DHEA) become detectable in vivo after consumption of diets rich in EPA and DHA 
(Wood et al., 2010) and are able to activate cannabinoid receptors (Brown et al., 2010). 
Lucanic and coworkers showed, that exogenous EPEA treatment decreased lifespan in 
wildtype worms and prevented lifespan increase in rsks-1(ok1255) mutants, a genetic 
model of dietary restriction (Lucanic et al., 2011; De Petroccellis and Di Marzo, 2011). 
Decrease in lifespan in worms with ectopic expression of CB2R supports the hypothesis 
that endocannabinoid signalling is involved in longevity regulation in C. elegans.  
Our results suggest a receptor mediated response controlling levels of endocannabinoid 
like molecules as well as their fatty acid precursors. We have not yet identified the exact 
signal transduction pathways and signaling partners of transgenic hCBRs in C. elegans. 
However, while an endogenous cannabinoid receptor ortholog in nematodes has not been 
identified, our results provide evidence that endocannabinoid levels could be regulated in 
C. elegans in a cannabinoid receptor pathway-like mechanism.   
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7 Conclusions and future prospects 
 
 
The nematode Caenorhabditis elegans as a model organism is becoming increasingly 
popular in biological and medical science, probably mostly for its cost-efficiency 
compared to other in vivo models.  It has proven to be an efficacious model for studying 
various biological processes, the area of implementation ranging from environmental 
studies to pharmacology, toxicology and basic molecular biology research. In last ten years 
several studies on C. elegans lipid metabolism have been published. The role of fatty acids 
and their derivatives in health and development has been neglected for a long time and 
has only in recent years caught the true attention of the scientific community.  In this 
thesis the benefits of this tiny worm as model organism are utilized to elucidate the 
importance of dietary fats, PUFAs and their derivatives in essential functions like 
development, breeding and feeding.  
 
I There exist a relatively high number of publications containing C. elegans microarray 
data mostly from development, aging and toxicology studies. Besides the many 
advantages there still are several disadvantages in using C. elegans in microarray 
experiments, but the first outweigh the latter, at least for studies concerning holo-
organismal physiological processes. 
 
II.1 The study of the effect of dietary elaidic acid, the trans-isomer of oleid acid, on C. 
elegans showed that in spite of no discernible harm caused by supplementary EA to wild 
type worms, the viability of animals with deficient PUFA metabolism was significantly 
impaired by this diet. This complements the studies with rodents with essential fatty acid 
deficit (Hill et al., 1979) as well as obese human patients (Christiansen et al., 1997; Lefevre 
et al., 2005), emphasizing the importance of the genotypic and phenotypic status of the 
subject in response to a diet rich of trans-fats. 
 
II.2 Comparison of the fatty acid profiles of the control and PUFA deficient worms grown 
on cis- or trans-isomer of oleic acid supplemented agar plates did not show any significant 
variability between treated and untreated animals. 
Gene expression profiles of those however provided a relatively copious amount of data. 
Although the actual molecular mechanisms of the deleterious effect of trans-fats on PUFA 
deficient animals were not revealed, the microarray gene lists offered a number hints to 
focus on in subsequent research.  
 
III & IV.1 The second part of the study concerns endocannabinoid system in nematodes. 
Our paper on identification of endocannabinoids 2-AG and AEA (III) and some of the 
other acylethanolamides (NAEs) (data not published) in three nematode species was the 
first published on C. elegans endocannabinoid research. A few years later Lucanic and 
coworkers published a paper showing the reduction of NAE levels under dietary 
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restriction in C. elegans, and furthermore,  NAE deficiency contributing to DR-induced 
lifespan extension (Lucanic et al., 2011). Our results confirm the reduced levels of NAEs, 
as well as show the reduction of 2-AG levels, in starved wildtype worms (IV).  
 
IV.2 We produced transgenic worms expressing human cannabinoid receptors (CB1R and 
CB2R) in all neurons. In these animals the effect of starvation on ECL levels was 
attenuated, suggesting the presence of an intact G protein signaling mechanism in C. 
elegans regulating the levels of 2-AG and NAE levels. The transgenic animals also 
displayed reduced life span and fertility (IV), as well as several behavioural abnormalities 
to be examined in a more detailed manner.   
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Lipids serve important functions as 
membrane constituents and also as 
energy storing molecules. Besides that, 
lipids and lipid structures participate 
directly as messengers or regulators 
of signal transduction. Despite the 
growing interest in the biology of 
lipids, the exact mechanisms how lipid 
homeostasis ties in with other systems 
in the cell to regulate cell physiology 
at large has still remained largely 
unstudied. The tiny nematode C. 
elegans has proven to be an efficacious 
model for studying various biological 
processes, in this thesis it was used 
to elucidate the importance of dietary 
fats, PUFAs and their derivatives in 
essential functions like development, 
breeding and feeding. 
